These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|||||||||||||||||||
(State or other jurisdiction of
incorporation or organization) |
|
|
|
(I.R.S. Employer Identification No.) | (Registrant’s telephone number, including area code) | ||||||||||||||||||
(Address of principal executive offices, including zip code) |
Securities registered pursuant to Section 12(b) of the Act:
|
||||||||
Title of each class |
Trading
Symbol(s) |
Name of exchange on
which registered |
||||||
|
|
|
||||||
Depositary Shares, each representing 1/1,000th interest in a share of Floating Rate |
|
|
||||||
|
||||||||
Depositary Shares, each representing 1/1,000th interest in a share of Fixed-to-Floating Rate |
|
|
||||||
|
||||||||
Depositary Shares, each representing 1/1,000th interest in a share of Fixed-to-Floating Rate |
|
|
||||||
|
||||||||
Depositary Shares, each representing 1/1,000th interest in a share of Fixed-to-Floating Rate |
|
|
||||||
|
||||||||
Depositary Shares, each representing 1/1,000th interest in a share of Fixed-to-Floating Rate |
|
|
||||||
|
||||||||
Depositary Shares, each representing 1/1,000th interest in a share of 4.875% |
|
|
||||||
|
||||||||
Depositary Shares, each representing 1/1,000th interest in a share of 4.250% |
|
|
||||||
|
||||||||
Depositary Shares, each representing 1/1,000th interest in a share of 6.500% |
|
|
||||||
|
||||||||
|
|
|
||||||
of Morgan Stanley Finance LLC (and Registrant’s guarantee with respect thereto) | ||||||||
|
|
|
||||||
of Morgan Stanley Finance LLC (and Registrant’s guarantee with respect thereto) |
|
☒ | Accelerated filer | ☐ | Non-accelerated filer | ☐ | Smaller reporting company |
|
Emerging growth company |
|
Table of Contents | Part | Item | Page | |||||||||||
I | ||||||||||||||
I | 2 | |||||||||||||
I | 3 | |||||||||||||
I | 1 | |||||||||||||
I | 4 | |||||||||||||
II | ||||||||||||||
II | 1 | |||||||||||||
II | 1A | |||||||||||||
II | 2 | |||||||||||||
II | 5 | |||||||||||||
II | 6 | |||||||||||||
i
|
ii
|
March 2023 Form 10-Q |
1
|
Management’s Discussion and Analysis |
![]() |
2
|
March 2023 Form 10-Q |
Management’s Discussion and Analysis |
![]() |
March 2023 Form 10-Q |
3
|
Management’s Discussion and Analysis |
![]() |
Three Months Ended
March 31, |
||||||||||||||
$ in millions | 2023 | 2022 | ||||||||||||
Consolidated results | ||||||||||||||
Net revenues | $ | 14,517 | $ | 14,801 | ||||||||||
Earnings applicable to Morgan Stanley common shareholders | $ | 2,836 | $ | 3,542 | ||||||||||
Earnings per diluted common share | $ | 1.70 | $ | 2.02 | ||||||||||
Consolidated financial measures | ||||||||||||||
Expense efficiency ratio
1
|
72 | % | 69 | % | ||||||||||
ROE
2
|
12.4 | % | 14.7 | % | ||||||||||
ROTCE
2, 3
|
16.9 | % | 19.8 | % | ||||||||||
Pre-tax margin
4
|
26 | % | 31 | % | ||||||||||
Effective tax rate | 19.3 | % | 19.0 | % | ||||||||||
Pre-tax margin by segment
4
|
||||||||||||||
Institutional Securities | 28 | % | 36 | % | ||||||||||
Wealth Management | 26 | % | 27 | % | ||||||||||
Investment Management | 13 | % | 17 | % | ||||||||||
in millions, except per share and employee data |
At
March 31, 2023 |
At
December 31, 2022 |
||||||
Average liquidity resources for three months ended
5
|
$ | 321,195 | $ | 312,250 | ||||
Loans
6
|
$ | 222,727 | $ | 222,182 | ||||
Total assets | $ | 1,199,904 | $ | 1,180,231 | ||||
Deposits | $ | 347,523 | $ | 356,646 | ||||
Borrowings | $ | 250,182 | $ | 238,058 | ||||
Common shareholders' equity | $ | 92,076 | $ | 91,391 | ||||
Tangible common shareholders’ equity
3
|
$ | 67,951 | $ | 67,123 | ||||
Common shares outstanding | 1,670 | 1,675 | ||||||
Book value per common share
7
|
$ | 55.13 | $ | 54.55 | ||||
Tangible book value per common share
3, 7
|
$ | 40.68 | $ | 40.06 | ||||
Worldwide employees (in thousands) | 82 | 82 | ||||||
Client assets
8
(in billions)
|
$ | 5,920 | $ | 5,492 | ||||
Capital Ratios
9
|
||||||||
Common Equity Tier 1 capital—Standardized | 15.1 | % | 15.3 | % | ||||
Tier 1 capital—Standardized | 17.0 | % | 17.2 | % | ||||
Common Equity Tier 1 capital—Advanced | 15.6 | % | 15.6 | % | ||||
Tier 1 capital—Advanced | 17.5 | % | 17.6 | % | ||||
Tier 1 leverage | 6.7 | % | 6.7 | % | ||||
SLR | 5.5 | % | 5.5 | % |
4
|
March 2023 Form 10-Q |
Management’s Discussion and Analysis |
![]() |
Three Months Ended
March 31, |
||||||||||||||
$ in millions, except per share data | 2023 | 2022 | ||||||||||||
Net revenues | $ | 14,517 | $ | 14,801 | ||||||||||
Adjustment for mark-to-market losses (gains) on certain employee deferred cash-based compensation plans
1
|
(153) | 441 | ||||||||||||
Adjusted Net revenues—non-GAAP | $ | 14,364 | $ | 15,242 | ||||||||||
Compensation expense | $ | 6,410 | $ | 6,274 | ||||||||||
Adjustment for mark-to-market gains (losses) on certain employee deferred cash-based compensation plans
1
|
(193) | 288 | ||||||||||||
Adjusted Compensation expense—non-GAAP | $ | 6,217 | $ | 6,562 | ||||||||||
Wealth Management Net revenues | $ | 6,559 | $ | 5,935 | ||||||||||
Adjustment for mark-to-market losses (gains) on certain employee deferred cash-based compensation plans
1
|
(101) | 296 | ||||||||||||
Adjusted Wealth Management Net revenues—non-GAAP | $ | 6,458 | $ | 6,231 | ||||||||||
Wealth Management Compensation expense | $ | 3,477 | $ | 3,125 | ||||||||||
Adjustment for mark-to-market gains (losses) on certain employee deferred cash-based compensation plans
1
|
(119) | 200 | ||||||||||||
Adjusted Wealth Management Compensation expense—non-GAAP | $ | 3,358 | $ | 3,325 | ||||||||||
$ in millions |
At
March 31, 2023 |
At
December 31, 2022 |
||||||
Tangible equity | ||||||||
Common shareholders’ equity | $ | 92,076 | $ | 91,391 | ||||
Less: Goodwill and net intangible assets | (24,125) | (24,268) | ||||||
Tangible common shareholders’ equity—non-GAAP | $ | 67,951 | $ | 67,123 |
Average Monthly Balance | ||||||||||||||
Three Months Ended
March 31, |
||||||||||||||
$ in millions | 2023 | 2022 | ||||||||||||
Tangible equity | ||||||||||||||
Common shareholders’ equity | $ | 91,382 | $ | 96,667 | ||||||||||
Less: Goodwill and net intangible assets | (24,198) | (25,120) | ||||||||||||
Tangible common shareholders’ equity—non-GAAP | $ | 67,184 | $ | 71,547 |
Three Months Ended
March 31, |
||||||||||||||
March 2023 Form 10-Q |
5
|
Management’s Discussion and Analysis |
![]() |
Three Months Ended
March 31, |
||||||||||||||
$ in billions | 2023 | 2022 | ||||||||||||
Average common equity
2
|
||||||||||||||
Institutional Securities | $ | 45.6 | $ | 48.8 | ||||||||||
Wealth Management | 28.8 | 31.0 | ||||||||||||
Investment Management | 10.4 | 10.6 | ||||||||||||
ROE
3
|
||||||||||||||
Institutional Securities | 12 | % | 17 | % | ||||||||||
Wealth Management | 19 | % | 16 | % | ||||||||||
Investment Management | 5 | % | 8 | % | ||||||||||
Average tangible common equity
2
|
||||||||||||||
Institutional Securities | $ | 45.2 | $ | 48.3 | ||||||||||
Wealth Management | 14.8 | 16.3 | ||||||||||||
Investment Management | 0.7 | 0.8 | ||||||||||||
ROTCE
3
|
||||||||||||||
Institutional Securities | 12 | % | 17 | % | ||||||||||
Wealth Management | 36 | % | 30 | % | ||||||||||
Investment Management | 73 | % | 106 | % |
6
|
March 2023 Form 10-Q |
Management’s Discussion and Analysis |
![]() |
Three Months Ended
March 31, |
% Change | ||||||||||
$ in millions | 2023 | 2022 | |||||||||
Revenues | |||||||||||
Advisory | $ | 638 | $ | 944 | (32) | % | |||||
Equity | 202 | 258 | (22) | % | |||||||
Fixed income | 407 | 432 | (6) | % | |||||||
Total Underwriting | 609 | 690 | (12) | % | |||||||
Total Investment banking | 1,247 | 1,634 | (24) | % | |||||||
Equity | 2,729 | 3,174 | (14) | % | |||||||
Fixed income | 2,576 | 2,923 | (12) | % | |||||||
Other | 245 | (74) | N/M | ||||||||
Net revenues | $ | 6,797 | $ | 7,657 | (11) | % | |||||
Provision for credit losses | 189 | 44 | N/M | ||||||||
Compensation and benefits | 2,365 | 2,604 | (9) | % | |||||||
Non-compensation expenses | 2,351 | 2,222 | 6 | % | |||||||
Total non-interest expenses | 4,716 | 4,826 | (2) | % | |||||||
Income before provision for income taxes | 1,892 | 2,787 | (32) | % | |||||||
Provision for income taxes | 363 | 535 | (32) | % | |||||||
Net income | 1,529 | 2,252 | (32) | % | |||||||
Net income applicable to noncontrolling interests | 51 | 61 | (16) | % | |||||||
Net income applicable to Morgan Stanley | $ | 1,478 | $ | 2,191 | (33) | % |
Three Months Ended
March 31, |
||||||||||||||
$ in billions | 2023 | 2022 | ||||||||||||
Completed mergers and acquisitions
1
|
$ | 129 | $ | 331 | ||||||||||
Equity and equity-related offerings
2, 3
|
10 | 8 | ||||||||||||
Fixed income offerings
2, 4
|
63 | 81 |
Three Months Ended March 31, 2023 | |||||||||||||||||
Net Interest
2
|
All Other
3
|
||||||||||||||||
$ in millions | Trading |
Fees
1
|
Total | ||||||||||||||
Financing | $ | 1,696 | $ | 134 | $ | (541) | $ | 32 | $ | 1,321 | |||||||
Execution services | 848 | 619 | (59) | — | 1,408 | ||||||||||||
Total Equity | $ | 2,544 | $ | 753 | $ | (600) | $ | 32 | $ | 2,729 | |||||||
Total Fixed Income | $ | 2,478 | $ | 109 | $ | (89) | $ | 78 | $ | 2,576 |
Three Months Ended March 31, 2022 | |||||||||||||||||
Net Interest
2
|
All Other
3
|
||||||||||||||||
$ in millions | Trading |
Fees
1
|
Total | ||||||||||||||
Financing | $ | 1,251 | $ | 132 | $ | 87 | $ | 4 | $ | 1,474 | |||||||
Execution services | 924 | 693 | (34) | 117 | 1,700 | ||||||||||||
Total Equity | $ | 2,175 | $ | 825 | $ | 53 | $ | 121 | $ | 3,174 | |||||||
Total Fixed Income | $ | 2,258 | $ | 97 | $ | 508 | $ | 60 | $ | 2,923 |
March 2023 Form 10-Q |
7
|
Management’s Discussion and Analysis |
![]() |
8
|
March 2023 Form 10-Q |
Management’s Discussion and Analysis |
![]() |
Three Months Ended
March 31, |
% Change | ||||||||||
$ in millions | 2023 | 2022 | |||||||||
Revenues | |||||||||||
Asset management | $ | 3,382 | $ | 3,626 | (7) | % | |||||
Transactional
1
|
921 | 635 | 45 | % | |||||||
Net interest | 2,158 | 1,540 | 40 | % | |||||||
Other
1
|
98 | 134 | (27) | % | |||||||
Net revenues | 6,559 | 5,935 | 11 | % | |||||||
Provision for credit losses | 45 | 13 | N/M | ||||||||
Compensation and benefits | 3,477 | 3,125 | 11 | % | |||||||
Non-compensation expenses | 1,325 | 1,224 | 8 | % | |||||||
Total non-interest expenses | 4,802 | 4,349 | 10 | % | |||||||
Income before provision for income taxes | $ | 1,712 | $ | 1,573 | 9 | % | |||||
Provision for income taxes | 336 | 301 | 12 | % | |||||||
Net income applicable to Morgan Stanley | $ | 1,376 | $ | 1,272 | 8 | % |
$ in billions |
At March 31,
2023 |
At December 31,
2022 |
||||||
Total client assets
1
|
$ | 4,558 | $ | 4,187 | ||||
U.S. Bank Subsidiary loans | $ | 144 | $ | 146 | ||||
Margin and other lending
2
|
$ | 21 | $ | 22 | ||||
Deposits
3
|
$ | 341 | $ | 351 | ||||
Annualized weighted average cost of deposits
4
|
||||||||
Period end | 2.05% | 1.59% | ||||||
Period average for three months ended | 1.86% | 1.32% |
Three Months Ended
March 31, |
||||||||||||||
2023 | 2022 | |||||||||||||
Net new assets
5
|
$ | 109.6 | $ | 142.0 |
$ in billions |
At March 31,
2023 |
At December 31,
2022 |
|||||||||
Advisor-led client assets
1
|
$ | 3,582 | $ | 3,392 | |||||||
Fee-based client assets
2
|
$ | 1,769 | $ | 1,678 | |||||||
Fee-based client assets as a percentage of advisor-led client assets | 49% | 49% |
Three Months Ended
March 31, |
||||||||||||||
2023 | 2022 | |||||||||||||
Fee-based asset flows
3
|
$ | 22.4 | $ | 97.2 |
$ in billions |
At March 31,
2023 |
At December 31,
2022 |
|||||||||
Self-directed assets
1
|
$ | 976 | $ | 795 | |||||||
Self-directed households (in millions)
2
|
8.1 | 8.0 |
Three Months Ended
March 31, |
||||||||||||||
2023 | 2022 | |||||||||||||
Daily average revenue trades (“DARTs”) (in thousands)
3
|
831 | 1,016 |
$ in billions |
At March 31,
2023 |
At December 31,
2022 |
|||||||||
Stock plan unvested assets
2
|
$ | 358 | $ | 302 | |||||||
Stock plan participants (in millions)
3
|
6.5 | 6.3 |
March 2023 Form 10-Q |
9
|
Management’s Discussion and Analysis |
![]() |
$ in billions |
At
December 31, 2022 |
Inflows | Outflows |
Market
Impact |
At
March 31, 2023 |
|||||||||||||||
Separately managed
1
|
$ | 501 | $ | 16 | $ | (7) | $ | 18 | $ | 528 | ||||||||||
Unified managed | 408 | 21 | (14) | 17 | 432 | |||||||||||||||
Advisor | 167 | 9 | (9) | 9 | 176 | |||||||||||||||
Portfolio manager | 552 | 26 | (20) | 20 | 578 | |||||||||||||||
Subtotal | $ | 1,628 | $ | 72 | $ | (50) | $ | 64 | $ | 1,714 | ||||||||||
Cash management | 50 | 20 | (15) | — | 55 | |||||||||||||||
Total fee-based
client assets
|
$ | 1,678 | $ | 92 | $ | (65) | $ | 64 | $ | 1,769 |
$ in billions |
At
December 31, 2021 |
Inflows
2
|
Outflows |
Market
Impact |
At
March 31, 2022 |
||||||||||||
Separately managed
1
|
$ | 479 | $ | 87 | $ | (8) | $ | 7 | $ | 565 | |||||||
Unified managed | 467 | 25 | (14) | (31) | 447 | ||||||||||||
Advisor | 211 | 9 | (11) | (10) | 199 | ||||||||||||
Portfolio manager | 636 | 30 | (21) | (30) | 615 | ||||||||||||
Subtotal | $ | 1,793 | $ | 151 | $ | (54) | $ | (64) | $ | 1,826 | |||||||
Cash management | 46 | 9 | (8) | — | 47 | ||||||||||||
Total fee-based
client assets
|
$ | 1,839 | $ | 160 | $ | (62) | $ | (64) | $ | 1,873 |
Three Months Ended
March 31, |
||||||||||||||
Fee rate in bps | 2023 | 2022 | ||||||||||||
Separately managed | 13 | 13 | ||||||||||||
Unified managed | 93 | 94 | ||||||||||||
Advisor | 80 | 81 | ||||||||||||
Portfolio manager | 91 | 92 | ||||||||||||
Subtotal | 66 | 68 | ||||||||||||
Cash management | 6 | 6 | ||||||||||||
Total fee-based client assets | 65 | 67 |
10
|
March 2023 Form 10-Q |
Management’s Discussion and Analysis |
![]() |
Three Months Ended
March 31, |
% Change | ||||||||||
$ in millions | 2023 | 2022 | |||||||||
Revenues |
|
||||||||||
Asset management and related fees | $ | 1,248 | $ | 1,388 | (10) | % | |||||
Performance-based income and other
1
|
41 | (53) | 177 | % | |||||||
Net revenues | 1,289 | 1,335 | (3) | % | |||||||
Compensation and benefits | 568 | 545 | 4 | % | |||||||
Non-compensation expenses | 555 | 562 | (1) | % | |||||||
Total non-interest expenses | 1,123 | 1,107 | 1 | % | |||||||
Income before provision for income taxes | 166 | 228 | (27) | % | |||||||
Provision for income taxes | 30 | 37 | (19) | % | |||||||
Net income | 136 | 191 | (29) | % | |||||||
Net income (loss) applicable to noncontrolling interests | 2 | (12) | 117 | % | |||||||
Net income applicable to Morgan Stanley | $ | 134 | $ | 203 | (34) | % |
$ in billions | Equity | Fixed Income | Alternatives and Solutions | Long-Term AUM Subtotal | Liquidity and Overlay Services | Total | ||||||||||||||
December 31, 2022 | $ | 259 | $ | 173 | $ | 431 | $ | 863 | $ | 442 | $ | 1,305 | ||||||||
Inflows | 10 | 16 | 18 | 44 | 585 | 629 | ||||||||||||||
Outflows | (12) | (17) | (16) | (45) | (568) | (613) | ||||||||||||||
Market Impact | 21 | 4 | 15 | 40 | 6 | 46 | ||||||||||||||
Other | (1) | (1) | — | (2) | (3) | (5) | ||||||||||||||
March 31, 2023 | $ | 277 | $ | 175 | $ | 448 | $ | 900 | $ | 462 | $ | 1,362 |
$ in billions | Equity | Fixed Income | Alternatives and Solutions | Long-Term AUM Subtotal | Liquidity and Overlay Services | Total | ||||||||||||||
December 31, 2021 | $ | 395 | $ | 207 | $ | 466 | $ | 1,068 | $ | 497 | $ | 1,565 | ||||||||
Inflows | 19 | 19 | 27 | 65 | 494 | 559 | ||||||||||||||
Outflows | (26) | (22) | (29) | (77) | (523) | (600) | ||||||||||||||
Market Impact | (48) | (7) | (14) | (69) | (2) | (71) | ||||||||||||||
Other | (3) | (2) | (1) | (6) | — | (6) | ||||||||||||||
March 31, 2022 | $ | 337 | $ | 195 | $ | 449 | $ | 981 | $ | 466 | $ | 1,447 |
Three Months Ended
March 31, |
||||||||||||||
$ in billions | 2023 | 2022 | ||||||||||||
Equity | $ | 271 | $ | 355 | ||||||||||
Fixed income | 175 | 201 | ||||||||||||
Alternatives and Solutions | 441 | 454 | ||||||||||||
Long-term AUM subtotal | 887 | 1010 | ||||||||||||
Liquidity and Overlay Services | 442 | 476 | ||||||||||||
Total AUM | $ | 1,329 | $ | 1,486 |
Three Months Ended
March 31, |
|||||||||||||||||
Fee rate in bps | 2023 | 2022 | |||||||||||||||
Equity | 72 | 70 | |||||||||||||||
Fixed income | 35 | 36 | |||||||||||||||
Alternatives and Solutions | 33 | 35 | |||||||||||||||
Long-term AUM | 45 | 48 | |||||||||||||||
Liquidity and Overlay Services | 13 | 7 | |||||||||||||||
Total AUM | 35 | 35 |
March 2023 Form 10-Q |
11
|
Management’s Discussion and Analysis |
![]() |
12
|
March 2023 Form 10-Q |
Management’s Discussion and Analysis |
![]() |
$ in billions |
At
March 31, 2023 |
At
December 31, 2022 |
||||||
Investment securities portfolio: | ||||||||
Investment securities—AFS | $ | 67.6 | $ | 66.9 | ||||
Investment securities—HTM | 55.7 | 56.4 | ||||||
Total investment securities | $ | 123.3 | $ | 123.3 | ||||
Wealth Management Loans
2
|
||||||||
Residential real estate | $ | 55.3 | $ | 54.4 | ||||
Securities-based lending and Other
3
|
88.4 | 91.7 | ||||||
Total, net of ACL | $ | 143.7 | $ | 146.1 | ||||
Institutional Securities Loans
2
|
||||||||
Corporate | $ | 8.3 | $ | 6.9 | ||||
Secured lending facilities | 38.3 | 37.1 | ||||||
Commercial and Residential real estate | 10.5 | 10.2 | ||||||
Securities-based lending and Other | 6.0 | 6.0 | ||||||
Total, net of ACL | $ | 63.1 | $ | 60.2 | ||||
Total Assets | $ | 384.8 | $ | 391.0 | ||||
Deposits
4
|
$ | 340.9 | $ | 350.6 |
March 2023 Form 10-Q |
13
|
Management’s Discussion and Analysis |
![]() |
At March 31, 2023 | ||||||||||||||
$ in millions | IS | WM | IM | Total | ||||||||||
Assets | ||||||||||||||
Cash and cash equivalents | $ | 84,356 | $ | 26,747 | $ | 155 | $ | 111,258 | ||||||
Trading assets at fair value | 310,842 | 4,560 | 4,899 | 320,301 | ||||||||||
Investment securities | 37,386 | 120,558 | — | 157,944 | ||||||||||
Securities purchased under agreements to resell | 108,722 | 13,163 | — | 121,885 | ||||||||||
Securities borrowed | 145,289 | 927 | — | 146,216 | ||||||||||
Customer and other receivables | 43,973 | 28,907 | 1,215 | 74,095 | ||||||||||
Loans
1
|
71,008 | 143,684 | 4 | 214,696 | ||||||||||
Other assets
2
|
17,619 | 24,859 | 11,031 | 53,509 | ||||||||||
Total assets | $ | 819,195 | $ | 363,405 | $ | 17,304 | $ | 1,199,904 |
At December 31, 2022 | ||||||||||||||
$ in millions | IS | WM | IM | Total | ||||||||||
Assets | ||||||||||||||
Cash and cash equivalents | $ | 88,362 | $ | 39,539 | $ | 226 | $ | 128,127 | ||||||
Trading assets at fair value | 294,884 | 1,971 | 4,460 | 301,315 | ||||||||||
Investment securities | 40,481 | 119,450 | — | 159,931 | ||||||||||
Securities purchased under agreements to resell | 102,511 | 11,396 | — | 113,907 | ||||||||||
Securities borrowed | 132,619 | 755 | — | 133,374 | ||||||||||
Customer and other receivables | 47,515 | 29,620 | 1,405 | 78,540 | ||||||||||
Loans
1
|
67,676 | 146,105 | 4 | 213,785 | ||||||||||
Other assets
2
|
15,789 | 24,469 | 10,994 | 51,252 | ||||||||||
Total assets | $ | 789,837 | $ | 373,305 | $ | 17,089 | $ | 1,180,231 |
Average Daily Balance
Three Months Ended |
||||||||
$ in millions |
March 31,
2023 |
December 31, 2022 | ||||||
Cash deposits with central banks | $ | 65,677 | $ | 58,818 | ||||
Unencumbered HQLA Securities
1
:
|
||||||||
U.S. government obligations | 132,225 | 136,020 | ||||||
U.S. agency and agency mortgage-backed securities | 92,219 | 87,591 | ||||||
Non-U.S. sovereign obligations
2
|
21,113 | 20,583 | ||||||
Other investment grade securities | 694 | 694 | ||||||
Total HQLA
1
|
$ | 311,928 | $ | 303,706 | ||||
Cash deposits with banks (non-HQLA) | 9,267 | 8,544 | ||||||
Total Liquidity Resources | $ | 321,195 | $ | 312,250 |
14
|
March 2023 Form 10-Q |
Management’s Discussion and Analysis |
![]() |
Average Daily Balance
Three Months Ended |
||||||||
$ in millions |
March 31,
2023 |
December 31, 2022 | ||||||
Bank legal entities | ||||||||
U.S. | $ | 140,029 | $ | 134,845 | ||||
Non-U.S. | 6,651 | 6,980 | ||||||
Total Bank legal entities | 146,680 | 141,825 | ||||||
Non-Bank legal entities | ||||||||
U.S.: | ||||||||
Parent Company | 52,315 | 56,111 | ||||||
Non-Parent Company | 58,027 | 54,813 | ||||||
Total U.S. | 110,342 | 110,924 | ||||||
Non-U.S. | 64,173 | 59,501 | ||||||
Total Non-Bank legal entities | 174,515 | 170,425 | ||||||
Total Liquidity Resources | $ | 321,195 | $ | 312,250 |
Average Daily Balance
Three Months Ended |
||||||||
$ in millions |
March 31,
2023 |
December 31, 2022 | ||||||
Eligible HQLA
1
|
||||||||
Cash deposits with central banks | $ | 58,133 | $ | 52,765 | ||||
Securities
2
|
185,375 | 186,551 | ||||||
Total Eligible HQLA
1
|
$ | 243,508 | $ | 239,316 | ||||
LCR | 135 | % | 132 | % |
$ in millions |
At
March 31, 2023 |
At
December 31, 2022 |
||||||
Securities purchased under agreements to resell and Securities borrowed | $ | 268,101 | $ | 247,281 | ||||
Securities sold under agreements to repurchase and Securities loaned | $ | 76,079 | $ | 78,213 | ||||
Securities received as collateral
1
|
$ | 9,867 | $ | 9,954 |
Average Daily Balance
Three Months Ended |
||||||||
$ in millions |
March 31,
2023 |
December 31,
2022 |
||||||
Securities purchased under agreements to resell and Securities borrowed | $ | 254,449 | $ | 261,627 | ||||
Securities sold under agreements to repurchase and Securities loaned | $ | 77,154 | $ | 77,268 |
March 2023 Form 10-Q |
15
|
Management’s Discussion and Analysis |
![]() |
$ in millions |
At
March 31, 2023 |
At
December 31, 2022 |
||||||
Savings and demand deposits: | ||||||||
Brokerage sweep deposits
1
|
$ | 175,448 | $ | 202,592 | ||||
Savings and other | 122,882 | 117,356 | ||||||
Total Savings and demand deposits | 298,330 | 319,948 | ||||||
Time deposits | 49,193 | 36,698 | ||||||
Total
2
|
$ | 347,523 | $ | 356,646 |
$ in millions | Parent Company | Subsidiaries | Total | ||||||||
Original maturities of one year or less | $ | — | $ | 4,587 | $ | 4,587 | |||||
Original maturities greater than one year | |||||||||||
2023 | $ | 4,504 | $ | 6,418 | $ | 10,922 | |||||
2024 | 19,858 | 11,897 | 31,755 | ||||||||
2025 | 21,666 | 9,428 | 31,094 | ||||||||
2026 | 24,066 | 6,267 | 30,333 | ||||||||
2027 | 18,855 | 6,876 | 25,731 | ||||||||
Thereafter | 85,715 | 30,045 | 115,760 | ||||||||
Total | $ | 174,664 | $ | 70,931 | $ | 245,595 | |||||
Total Borrowings | $ | 174,664 | $ | 75,518 | $ | 250,182 | |||||
Maturities over next 12 months
2
|
$ | 20,382 |
Parent Company | |||||||||||
Short-Term Debt | Long-Term Debt | Rating Outlook | |||||||||
DBRS, Inc. | R-1 (middle) | A (high) | Stable | ||||||||
Fitch Ratings, Inc. | F1 | A+ | Stable | ||||||||
Moody’s Investors Service, Inc. | P-1 | A1 | Stable | ||||||||
Rating and Investment Information, Inc. | a-1 | A | Positive | ||||||||
S&P Global Ratings | A-2 | A- | Stable |
MSBNA | |||||||||||
Short-Term Debt | Long-Term Debt | Rating Outlook | |||||||||
Fitch Ratings, Inc. | F1+ | AA- | Stable | ||||||||
Moody’s Investors Service, Inc. | P-1 | Aa3 | Stable | ||||||||
S&P Global Ratings | A-1 | A+ | Stable |
MSPBNA | |||||||||||
Short-Term Debt | Long-Term Debt | Rating Outlook | |||||||||
Moody’s Investors Service, Inc. | P-1 | Aa3 | Stable | ||||||||
S&P Global Ratings | A-1 | A+ | Stable |
16
|
March 2023 Form 10-Q |
Management’s Discussion and Analysis |
![]() |
Three Months Ended
March 31, |
||||||||||||||
in millions, except for per share data | 2023 | 2022 | ||||||||||||
Number of shares | 16 | 30 | ||||||||||||
Average price per share | $ | 95.16 | $ | 95.20 | ||||||||||
Total | $ | 1,500 | $ | 2,872 |
Announcement date | April 19, 2023 | ||||
Amount per share | $0.775 | ||||
Date to be paid | May 15, 2023 | ||||
Shareholders of record as of | May 1, 2023 |
March 2023 Form 10-Q |
17
|
Management’s Discussion and Analysis |
![]() |
At March 31, 2023
and
December 31, 2022
|
||||||||
Standardized | Advanced | |||||||
Capital buffers | ||||||||
Capital conservation buffer | — | 2.5% | ||||||
SCB
1
|
5.8% | N/A | ||||||
G-SIB capital surcharge
2
|
3.0% | 3.0% | ||||||
CCyB
3
|
0 | 0 | ||||||
Capital buffer requirement | 8.8% | 5.5% |
Regulatory Minimum |
At March 31, 2023
and
December 31, 2022
|
||||||||||
Standardized | Advanced | ||||||||||
Required ratios
1
|
|||||||||||
Common Equity Tier 1 capital ratio | 4.5 | % | 13.3% | 10.0% | |||||||
Tier 1 capital ratio | 6.0 | % | 14.8% | 11.5% | |||||||
Total capital ratio | 8.0 | % | 16.8% | 13.5% |
$ in millions |
Required
Ratio 1 |
At March 31,
2023 |
At December 31, 2022 | |||||||||||||||||
Risk-based capital—
Standardized |
||||||||||||||||||||
Common Equity Tier 1 capital | $ | 69,454 | $ | 68,670 | ||||||||||||||||
Tier 1 capital | 77,947 | 77,191 | ||||||||||||||||||
Total capital | 89,794 | 86,575 | ||||||||||||||||||
Total RWA | 459,107 | 447,849 | ||||||||||||||||||
Common Equity Tier 1 capital ratio | 13.3 | % | 15.1 | % | 15.3 | % | ||||||||||||||
Tier 1 capital ratio | 14.8 | % | 17.0 | % | 17.2 | % | ||||||||||||||
Total capital ratio | 16.8 | % | 19.6 | % | 19.3 | % |
$ in millions |
Required
Ratio 1 |
At March 31,
2023 |
At December 31, 2022 | ||||||||
Risk-based capital—
Advanced |
|||||||||||
Common Equity Tier 1 capital | $ | 69,454 | $ | 68,670 | |||||||
Tier 1 capital | 77,947 | 77,191 | |||||||||
Total capital | 89,321 | 86,159 | |||||||||
Total RWA | 444,796 | 438,806 | |||||||||
Common Equity Tier 1 capital ratio | 10.0 | % | 15.6 | % | 15.6 | % | |||||
Tier 1 capital ratio | 11.5 | % | 17.5 | % | 17.6 | % | |||||
Total capital ratio | 13.5 | % | 20.1 | % | 19.6 | % | |||||
$ in millions |
Required
Ratio
1
|
At March 31,
2023 |
At December 31, 2022 | ||||||||
Leverage-based capital | |||||||||||
Adjusted average assets
2
|
$ | 1,168,328 | $ | 1,150,772 | |||||||
Tier 1 leverage ratio | 4.0 | % | 6.7 | % | 6.7 | % | |||||
Supplementary leverage exposure
3
|
$ | 1,422,808 | $ | 1,399,403 | |||||||
SLR | 5.0 | % | 5.5 | % | 5.5 | % |
18
|
March 2023 Form 10-Q |
Management’s Discussion and Analysis |
![]() |
$ in millions |
At
March 31, 2023 |
At
December 31, 2022 |
Change | ||||||||
Common Equity Tier 1 capital | |||||||||||
Common stock and surplus | $ | 1,395 | $ | 2,782 | $ | (1,387) | |||||
Retained earnings | 96,516 | 95,047 | 1,469 | ||||||||
AOCI | (5,711) | (6,253) | 542 | ||||||||
Regulatory adjustments and deductions: | |||||||||||
Net goodwill | (16,388) | (16,393) | 5 | ||||||||
Net intangible assets | (5,914) | (6,048) | 134 | ||||||||
Other adjustments and deductions
1
|
(444) | (465) | 21 | ||||||||
Total Common Equity Tier 1 capital | $ | 69,454 | $ | 68,670 | $ | 784 | |||||
Additional Tier 1 capital | |||||||||||
Preferred stock | $ | 8,750 | $ | 8,750 | $ | — | |||||
Noncontrolling interests | 571 | 552 | 19 | ||||||||
Additional Tier 1 capital | $ | 9,321 | $ | 9,302 | $ | 19 | |||||
Deduction for investments in covered funds | (828) | (781) | (47) | ||||||||
Total Tier 1 capital | $ | 77,947 | $ | 77,191 | $ | 756 | |||||
Standardized Tier 2 capital | |||||||||||
Subordinated debt | $ | 9,997 | $ | 7,846 | $ | 2,151 | |||||
Eligible ACL | 1,898 | 1,613 | 285 | ||||||||
Other adjustments and deductions | (48) | (75) | 27 | ||||||||
Total Standardized Tier 2 capital | $ | 11,847 | $ | 9,384 | $ | 2,463 | |||||
Total Standardized capital | $ | 89,794 | $ | 86,575 | $ | 3,219 | |||||
Advanced Tier 2 capital | |||||||||||
Subordinated debt | $ | 9,997 | $ | 7,846 | $ | 2,151 | |||||
Eligible credit reserves | 1,425 | 1,197 | 228 | ||||||||
Other adjustments and deductions | (48) | (75) | 27 | ||||||||
Total Advanced Tier 2 capital | $ | 11,374 | $ | 8,968 | $ | 2,406 | |||||
Total Advanced capital | $ | 89,321 | $ | 86,159 | $ | 3,162 |
Three Months Ended
March 31, 2023 |
||||||||
$ in millions | Standardized | Advanced | ||||||
Credit risk RWA | ||||||||
Balance at December 31, 2022 | $ | 397,275 | $ | 285,638 | ||||
Change related to the following items: | ||||||||
Derivatives | 1,388 | 1,399 | ||||||
Securities financing transactions | 4,672 | 1,842 | ||||||
Investment securities | (290) | 77 | ||||||
Commitments, guarantees and loans | (1,968) | 1,374 | ||||||
Equity investments | (370) | (380) | ||||||
Other credit risk | 5,258 | 4,714 | ||||||
Total change in credit risk RWA | $ | 8,690 | $ | 9,026 | ||||
Balance at March 31, 2023 | $ | 405,965 | $ | 294,664 | ||||
Market risk RWA | ||||||||
Balance at December 31, 2022 | $ | 50,574 | $ | 50,563 | ||||
Change related to the following items: | ||||||||
Regulatory VaR | 242 | 242 | ||||||
Regulatory stressed VaR | (1,042) | (1,042) | ||||||
Incremental risk charge | (405) | (405) | ||||||
Comprehensive risk measure | 24 | (84) | ||||||
Specific risk | 3,749 | 3,749 | ||||||
Total change in market risk RWA | $ | 2,568 | $ | 2,460 | ||||
Balance at March 31, 2023 | $ | 53,142 | $ | 53,023 | ||||
Operational risk RWA | ||||||||
Balance at December 31, 2022 | N/A | $ | 102,605 | |||||
Change in operational risk RWA | N/A | (5,496) | ||||||
Balance at March 31, 2023 | N/A | $ | 97,109 | |||||
Total RWA | $ | 459,107 | $ | 444,796 |
March 2023 Form 10-Q |
19
|
Management’s Discussion and Analysis |
![]() |
Actual Amount/Ratio | ||||||||||||||
$ in millions | Regulatory Minimum |
Required Ratio
1
|
At
March 31, 2023 |
At
December 31, 2022 |
||||||||||
External TLAC
2
|
$ | 250,191 | $ | 245,951 | ||||||||||
External TLAC as a % of RWA | 18.0 | % | 21.5 | % | 54.5 | % | 54.9 | % | ||||||
External TLAC as a % of leverage exposure | 7.5 | % | 9.5 | % | 17.6 | % | 17.6 | % | ||||||
Eligible LTD
3
|
$ | 162,775 | $ | 159,444 | ||||||||||
Eligible LTD as a % of RWA | 9.0 | % | 9.0 | % | 35.5 | % | 35.6 | % | ||||||
Eligible LTD as a % of leverage exposure | 4.5 | % | 4.5 | % | 11.4 | % | 11.4 | % |
Three Months Ended
March 31, |
||||||||||||||
$ in billions | 2023 | 2022 | ||||||||||||
Institutional Securities | $ | 45.6 | $ | 48.8 | ||||||||||
Wealth Management | 28.8 | 31.0 | ||||||||||||
Investment Management | 10.4 | 10.6 | ||||||||||||
Parent | 6.6 | 6.3 | ||||||||||||
Total | $ | 91.4 | $ | 96.7 |
20
|
March 2023 Form 10-Q |
Management’s Discussion and Analysis |
![]() |
March 2023 Form 10-Q |
21
|
Management’s Discussion and Analysis |
![]() |
22
|
March 2023 Form 10-Q |
Three Months Ended | ||||||||||||||
March 31, 2023 | ||||||||||||||
$ in millions | Period End | Average |
High
1
|
Low
1
|
||||||||||
Interest rate and credit spread | $ | 32 | $ | 36 | $ | 43 | $ | 31 | ||||||
Equity price | 29 | 25 | 31 | 16 | ||||||||||
Foreign exchange rate | 10 | 10 | 18 | 6 | ||||||||||
Commodity price | 21 | 24 | 35 | 16 | ||||||||||
Less: Diversification benefit
2
|
(44) | (47) | N/A | N/A | ||||||||||
Primary Risk Categories | $ | 48 | $ | 48 | $ | 60 | $ | 39 | ||||||
Credit Portfolio | 21 | 19 | 21 | 18 | ||||||||||
Less: Diversification benefit
2
|
(19) | (12) | N/A | N/A | ||||||||||
Total Management VaR | $ | 50 | $ | 55 | $ | 72 | $ | 45 |
Three Months Ended | ||||||||||||||
December 31, 2022 | ||||||||||||||
$ in millions | Period End | Average |
High
1
|
Low
1
|
||||||||||
Interest rate and credit spread | $ | 37 | $ | 36 | $ | 43 | $ | 32 | ||||||
Equity price | 16 | 20 | 28 | 16 | ||||||||||
Foreign exchange rate | 10 | 9 | 12 | 7 | ||||||||||
Commodity price | 26 | 30 | 41 | 20 | ||||||||||
Less: Diversification benefit
2
|
(36) | (39) | N/A | N/A | ||||||||||
Primary Risk Categories | $ | 53 | $ | 56 | $ | 65 | $ | 47 | ||||||
Credit Portfolio | 19 | 18 | 19 | 15 | ||||||||||
Less: Diversification benefit
2
|
(9) | (10) | N/A | N/A | ||||||||||
Total Management VaR | $ | 63 | $ | 64 | $ | 71 | $ | 56 |
March 2023 Form 10-Q |
23
|
Risk Disclosures |
![]() |
$ in millions |
At
March 31, 2023 |
At
December 31, 2022 |
||||||
Derivatives | $ | 6 | $ | 7 | ||||
Borrowings carried at fair value | 42 | 39 |
$ in millions |
At
March 31, 2023 |
At
December 31, 2022 |
||||||
Basis point change | ||||||||
+100 | $ | 533 | $ | 643 | ||||
-100 | (637) | (745) |
24
|
March 2023 Form 10-Q |
Risk Disclosures |
![]() |
Loss from 10% Decline | ||||||||
$ in millions |
At
March 31, 2023 |
At
December 31, 2022 |
||||||
Investments related to Investment Management activities | $ | 449 | $ | 431 | ||||
Other investments: | ||||||||
MUMSS | 144 | 143 | ||||||
Other Firm investments | 375 | 378 |
At March 31, 2023 | ||||||||||||||
$ in millions | HFI | HFS |
FVO
2
|
Total | ||||||||||
Institutional Securities: | ||||||||||||||
Corporate | $ | 7,435 | $ | 11,150 | $ | — | $ | 18,585 | ||||||
Secured lending facilities | 37,187 | 3,006 | 6 | 40,199 | ||||||||||
Commercial and Residential real estate | 8,601 | 948 | 2,535 | 12,084 | ||||||||||
Securities-based lending and Other | 3,430 | 16 | 5,276 | 8,722 | ||||||||||
Total Institutional Securities | 56,653 | 15,120 | 7,817 | 79,590 | ||||||||||
Wealth Management: | ||||||||||||||
Residential real estate | 55,400 | 25 | — | 55,425 | ||||||||||
Securities-based lending and Other | 88,463 | 1 | — | 88,464 | ||||||||||
Total Wealth Management | 143,863 | 26 | — | 143,889 | ||||||||||
Total Investment Management
1
|
4 | — | 214 | 218 | ||||||||||
Total loans | 200,520 | 15,146 | 8,031 | 223,697 | ||||||||||
ACL | (970) | (970) | ||||||||||||
Total loans, net of ACL | $ | 199,550 | $ | 15,146 | $ | 8,031 | $ | 222,727 | ||||||
Lending commitments
3
|
$ | 140,096 | ||||||||||||
Total exposure |
|
|
|
$ | 362,823 |
At December 31, 2022 | ||||||||||||||
$ in millions | HFI | HFS |
FVO
2
|
Total | ||||||||||
Institutional Securities: | ||||||||||||||
Corporate | $ | 6,589 | $ | 10,634 | $ | — | $ | 17,223 | ||||||
Secured lending facilities | 35,606 | 3,176 | 6 | 38,788 | ||||||||||
Commercial and Residential real estate | 8,515 | 926 | 2,548 | 11,989 | ||||||||||
Securities-based lending and Other | 2,865 | 39 | 5,625 | 8,529 | ||||||||||
Total Institutional Securities | 53,575 | 14,775 | 8,179 | 76,529 | ||||||||||
Wealth Management: | ||||||||||||||
Residential real estate | 54,460 | 4 | — | 54,464 | ||||||||||
Securities-based lending and Other | 91,797 | 9 | — | 91,806 | ||||||||||
Total Wealth Management | 146,257 | 13 | — | 146,270 | ||||||||||
Total Investment Management
1
|
4 | — | 218 | 222 | ||||||||||
Total loans | 199,836 | 14,788 | 8,397 | 223,021 | ||||||||||
ACL | (839) | (839) | ||||||||||||
Total loans, net of ACL | $ | 198,997 | $ | 14,788 | $ | 8,397 | $ | 222,182 | ||||||
Lending commitments
3
|
$ | 136,960 | ||||||||||||
Total exposure |
|
|
|
$ | 359,142 |
March 2023 Form 10-Q |
25
|
Risk Disclosures |
![]() |
$ in millions | |||||
ACL—Loans | $ | 839 | |||
ACL—Lending Commitments | 504 | ||||
Total at December 31, 2022
|
1,343 | ||||
Gross charge-offs | (71) | ||||
Provision for credit losses | 234 | ||||
Other | 3 | ||||
Total at March 31, 2023 | $ | 1,509 | |||
ACL—Loans | $ | 970 | |||
ACL—Lending commitments | 539 |
Three Months Ended March 31, 2023 | ||||||||||||||||||||
$ in millions | IS | WM | Total | |||||||||||||||||
Loans | $ | 160 | $ | 41 | $ | 201 | ||||||||||||||
Lending commitments | 29 | 4 | 33 | |||||||||||||||||
Total | $ | 189 | $ | 45 | $ | 234 |
4Q 2023 | 4Q 2024 | |||||||
Year-over-year growth rate | (0.1) | % | 2.0 | % |
At March 31, 2023 | At December 31, 2022 | |||||||||||||
IS | WM | IS | WM | |||||||||||
Accrual | 98.9 | % | 99.9 | % | 99.3 | % | 99.9 | % | ||||||
Nonaccrual
1
|
1.1 | % | 0.1 | % | 0.7 | % | 0.1 | % |
$ in millions | Corporate | Secured Lending Facilities | CRE | Residential Real Estate | SBL and Other | Total | ||||||||||||||
For the Three Months Ended March 31, 2023 | ||||||||||||||||||||
Net charge-off (recovery) ratio
1
|
0.01 | % | — | % | 0.81 | % | — | % | — | % | 0.04 | % | ||||||||
Average loans | $ | 6,953 | $ | 36,322 | $ | 8,568 | $ | 54,802 | $ | 93,021 | $ | 199,666 | ||||||||
For the Three Months Ended March 31, 2022 | ||||||||||||||||||||
Net charge-off ratio
1
|
— | % | 0.01 | % | 0.09 | % | — | % | — | % | 0.01 | % | ||||||||
Average loans | $ | 5,802 | $ | 31,353 | $ | 7,805 | $ | 45,521 | $ | 87,900 | $ | 178,381 | ||||||||
At March 31, 2023 | |||||||||||||||||
Contractual Years to Maturity | |||||||||||||||||
$ in millions | <1 | 1-5 | 5-15 | >15 | Total | ||||||||||||
Loans | |||||||||||||||||
AA | $ | 48 | $ | — | $ | 105 | $ | — | $ | 153 | |||||||
A | 1,184 | 2,020 | 186 | — | 3,390 | ||||||||||||
BBB | 5,157 | 11,706 | 453 | — | 17,316 | ||||||||||||
BB | 13,020 | 17,732 | 623 | 377 | 31,752 | ||||||||||||
Other NIG | 7,942 | 11,081 | 3,440 | 181 | 22,644 | ||||||||||||
Unrated
2
|
72 | 956 | 586 | 1,956 | 3,570 | ||||||||||||
Total loans, net of ACL | 27,423 | 43,495 | 5,393 | 2,514 | 78,825 | ||||||||||||
Lending commitments | |||||||||||||||||
AAA | — | 50 | — | — | 50 | ||||||||||||
AA | 2,273 | 2,775 | 289 | — | 5,337 | ||||||||||||
A | 5,336 | 19,947 | 407 | — | 25,690 | ||||||||||||
BBB | 11,852 | 41,144 | 747 | — | 53,743 | ||||||||||||
BB | 3,680 | 17,212 | 863 | 171 | 21,926 | ||||||||||||
Other NIG | 1,226 | 13,411 | 861 | 3 | 15,501 | ||||||||||||
Unrated
2
|
2 | 5 | — | — | 7 | ||||||||||||
Total lending commitments | 24,369 | 94,544 | 3,167 | 174 | 122,254 | ||||||||||||
Total exposure | $ | 51,792 | $ | 138,039 | $ | 8,560 | $ | 2,688 | $ | 201,079 |
26
|
March 2023 Form 10-Q |
Risk Disclosures |
![]() |
At December 31, 2022 | |||||||||||||||||
Contractual Years to Maturity | |||||||||||||||||
$ in millions | <1 | 1-5 | 5-15 | >15 | Total | ||||||||||||
Loans | |||||||||||||||||
AA | $ | 66 | $ | — | $ | 139 | $ | — | $ | 205 | |||||||
A | 1,331 | 787 | 185 | — | 2,303 | ||||||||||||
BBB | 5,632 | 10,712 | 465 | — | 16,809 | ||||||||||||
BB | 11,045 | 19,219 | 796 | 162 | 31,222 | ||||||||||||
Other NIG | 7,274 | 10,249 | 3,945 | 139 | 21,607 | ||||||||||||
Unrated
2
|
95 | 924 | 624 | 2,066 | 3,709 | ||||||||||||
Total loans, net of ACL | 25,443 | 41,891 | 6,154 | 2,367 | 75,855 | ||||||||||||
Lending commitments | |||||||||||||||||
AAA | — | 50 | — | — | 50 | ||||||||||||
AA | 2,515 | 2,935 | 11 | — | 5,461 | ||||||||||||
A | 5,030 | 19,717 | 202 | 330 | 25,279 | ||||||||||||
BBB | 10,263 | 39,615 | 566 | — | 50,444 | ||||||||||||
BB | 3,691 | 17,656 | 1,416 | 96 | 22,859 | ||||||||||||
Other NIG | 1,173 | 13,872 | 530 | — | 15,575 | ||||||||||||
Unrated
2
|
— | 20 | — | 3 | 23 | ||||||||||||
Total lending commitments | 22,672 | 93,865 | 2,725 | 429 | 119,691 | ||||||||||||
Total exposure | $ | 48,115 | $ | 135,756 | $ | 8,879 | $ | 2,796 | $ | 195,546 |
$ in millions |
At
March 31, 2023 |
At
December 31, 2022 |
||||||
Industry | ||||||||
Financials | $ | 52,298 | $ | 54,222 | ||||
Real estate | 36,203 | 32,358 | ||||||
Communications services | 14,857 | 15,336 | ||||||
Industrials | 14,620 | 14,557 | ||||||
Information technology | 14,379 | 13,790 | ||||||
Healthcare | 12,506 | 12,353 | ||||||
Utilities | 11,730 | 10,542 | ||||||
Consumer discretionary | 11,540 | 11,592 | ||||||
Consumer staples | 10,317 | 7,823 | ||||||
Energy | 8,672 | 9,115 | ||||||
Materials | 6,210 | 6,102 | ||||||
Insurance | 5,979 | 5,925 | ||||||
Other | 1,768 | 1,831 | ||||||
Total exposure | $ | 201,079 | $ | 195,546 |
At March 31, 2023 | |||||||||||||||||
Contractual Years to Maturity | |||||||||||||||||
$ in millions | <1 | 1-5 | 5-15 | Total | |||||||||||||
Loans, net of ACL | $ | 2,361 | $ | 1,193 | $ | 2,401 | $ | 5,955 | |||||||||
Lending commitments | 4,507 | 481 | 459 | 5,447 | |||||||||||||
Total exposure | $ | 6,868 | $ | 1,674 | $ | 2,860 | $ | 11,402 |
At December 31, 2022 | |||||||||||||||||
Contractual Years to Maturity | |||||||||||||||||
$ in millions | <1 | 1-5 | 5-15 | Total | |||||||||||||
Loans, net of ACL | $ | 2,385 | $ | 1,441 | $ | 2,771 | $ | 6,597 | |||||||||
Lending commitments | 3,079 | 861 | 603 | 4,543 | |||||||||||||
Total exposure | $ | 5,464 | $ | 2,302 | $ | 3,374 | $ | 11,140 |
At March 31, 2023 | |||||||||||||||||
$ in millions | Loans | Lending Commitments | Total | ||||||||||||||
Corporate | $ | 7,435 | $ | 82,758 | $ | 90,193 | |||||||||||
Secured lending facilities | 37,187 | 13,893 | 51,080 | ||||||||||||||
Commercial real estate | 8,601 | 371 | 8,972 | ||||||||||||||
Securities-based lending and Other | 3,430 | 955 | 4,385 | ||||||||||||||
Total, before ACL | $ | 56,653 | $ | 97,977 | $ | 154,630 | |||||||||||
ACL | $ | (765) | $ | (515) | $ | (1,280) |
At December 31, 2022 | |||||||||||||||||
$ in millions | Loans | Lending Commitments | Total | ||||||||||||||
Corporate | $ | 6,589 | $ | 79,882 | $ | 86,471 | |||||||||||
Secured lending facilities | 35,606 | 12,803 | 48,409 | ||||||||||||||
Commercial real estate | 8,515 | 374 | 8,889 | ||||||||||||||
Securities-based lending and Other | 2,865 | 985 | 3,850 | ||||||||||||||
Total, before ACL | $ | 53,575 | $ | 94,044 | $ | 147,619 | |||||||||||
ACL | $ | (674) | $ | (484) | $ | (1,158) |
March 2023 Form 10-Q |
27
|
Risk Disclosures |
![]() |
At March 31, 2023 | At December 31, 2022 | ||||||||||||||||||||||
$ in millions |
Loans
1
|
LC
1
|
Total |
Loans
1
|
LC
1
|
Total | |||||||||||||||||
Americas | $ | 6,103 | $ | 367 | $ | 6,470 | $ | 6,320 | $ | 378 | $ | 6,698 | |||||||||||
EMEA | 3,367 | 84 | 3,451 | 3,040 | 79 | 3,119 | |||||||||||||||||
Asia | 427 | 5 | 432 | 445 | 5 | 450 | |||||||||||||||||
Total
|
$ | 9,897 | $ | 456 | $ | 10,353 | $ | 9,805 | $ | 462 | $ | 10,267 |
At March 31, 2023 | At December 31, 2022 | ||||||||||||||||||||||
$ in millions |
Loans
1
|
LC
1
|
Total |
Loans
1
|
LC
1
|
Total | |||||||||||||||||
Office | $ | 3,869 | $ | 273 | $ | 4,142 | $ | 3,861 | $ | 301 | $ | 4,162 | |||||||||||
Industrial | 2,689 | 18 | 2,707 | 2,561 | 25 | 2,586 | |||||||||||||||||
Multifamily | 1,647 | 82 | 1,729 | 1,889 | 85 | 1,974 | |||||||||||||||||
Retail | 846 | 6 | 852 | 659 | 6 | 665 | |||||||||||||||||
Hotel | 834 | 77 | 911 | 780 | 45 | 825 | |||||||||||||||||
Other | 12 | — | 12 | 55 | — | 55 | |||||||||||||||||
Total
|
$ | 9,897 | $ | 456 | $ | 10,353 | $ | 9,805 | $ | 462 | $ | 10,267 |
$ in millions | Corporate | Secured Lending Facilities | Commercial Real Estate | Other | Total | ||||||||||||
ACL—Loans | $ | 235 | $ | 153 | $ | 275 | $ | 11 | $ | 674 | |||||||
ACL—Lending commitments | 411 | 51 | 15 | 7 | 484 | ||||||||||||
Total at December 31, 2022
|
$ | 646 | $ | 204 | $ | 290 | $ | 18 | $ | 1,158 | |||||||
Gross charge-offs | (1) | — | (69) | — | (70) | ||||||||||||
Provision for credit losses | 53 | — | 136 | — | 189 | ||||||||||||
Other | 2 | (1) | — | 2 | 3 | ||||||||||||
Total at March 31, 2023 | $ | 700 | $ | 203 | $ | 357 | $ | 20 | $ | 1,280 | |||||||
ACL—Loans | $ | 265 | $ | 152 | $ | 335 | $ | 13 | $ | 765 | |||||||
ACL—Lending commitments | 435 | 51 | 22 | 7 | 515 |
At
March 31, 2023 |
At
December 31, 2022 |
|||||||
Corporate | 3.6 | % | 3.6 | % | ||||
Secured lending facilities | 0.4 | % | 0.4 | % | ||||
Commercial real estate | 3.9 | % | 3.2 | % | ||||
Securities-based lending and Other | 0.4 | % | 0.4 | % | ||||
Total Institutional Securities loans | 1.4 | % | 1.3 | % |
At March 31, 2023 | |||||||||||||||||
Contractual Years to Maturity | |||||||||||||||||
$ in millions | <1 | 1-5 | 5-15 | >15 | Total | ||||||||||||
Securities-based lending and Other loans | $ | 76,801 | $ | 9,789 | $ | 1,647 | $ | 137 | $ | 88,374 | |||||||
Residential real estate loans | 1 | 39 | 1,351 | 53,919 | 55,310 | ||||||||||||
Total loans, net of ACL | $ | 76,802 | $ | 9,828 | $ | 2,998 | $ | 54,056 | $ | 143,684 | |||||||
Lending commitments | 12,985 | 4,492 | 32 | 333 | 17,842 | ||||||||||||
Total exposure | $ | 89,787 | $ | 14,320 | $ | 3,030 | $ | 54,389 | $ | 161,526 |
At December 31, 2022 | |||||||||||||||||
Contractual Years to Maturity | |||||||||||||||||
$ in millions | <1 | 1-5 | 5-15 | >15 | Total | ||||||||||||
Securities-based lending and Other loans | $ | 80,526 | $ | 9,371 | $ | 1,692 | $ | 140 | $ | 91,729 | |||||||
Residential real estate loans | 1 | 32 | 1,375 | 52,968 | 54,376 | ||||||||||||
Total loans, net of ACL | $ | 80,527 | $ | 9,403 | $ | 3,067 | $ | 53,108 | $ | 146,105 | |||||||
Lending commitments | 12,408 | 4,501 | 37 | 323 | 17,269 | ||||||||||||
Total exposure | $ | 92,935 | $ | 13,904 | $ | 3,104 | $ | 53,431 | $ | 163,374 |
28
|
March 2023 Form 10-Q |
Risk Disclosures |
![]() |
At March 31, 2023 | At December 31, 2022 | ||||||||||||||||||||||
$ in millions |
Loans
1
|
LC | Total |
Loans
1
|
LC | Total | |||||||||||||||||
Office | $ | 1,669 | $ | 1 | $ | 1,670 | $ | 1,675 | $ | 1 | $ | 1,676 | |||||||||||
Industrial | 330 | — | 330 | 330 | — | 330 | |||||||||||||||||
Multifamily | 1,848 | 140 | 1,988 | 1,661 | 142 | 1,803 | |||||||||||||||||
Retail | 2,125 | 9 | 2,134 | 2,135 | 6 | 2,141 | |||||||||||||||||
Hotel | 418 | — | 418 | 419 | — | 419 | |||||||||||||||||
Other | 185 | 10 | 195 | 183 | 10 | 193 | |||||||||||||||||
Total
|
$ | 6,575 | $ | 160 | $ | 6,735 | $ | 6,403 | $ | 159 | $ | 6,562 |
$ in millions | |||||
ACL—Loans | $ | 165 | |||
ACL—Lending commitments | 20 | ||||
Total at December 31, 2022
|
185 | ||||
Gross charge-offs | (1) | ||||
Provision for credit losses | 45 | ||||
Total at March 31, 2023 | $ | 229 | |||
ACL—Loans | $ | 205 | |||
ACL—Lending commitments | 24 |
$ in millions |
At
March 31, 2023 |
At
December 31, 2022 |
||||||
Institutional Securities | $ | 18,304 | $ | 16,591 | ||||
Wealth Management | 21,050 | 21,933 | ||||||
Total | $ | 39,354 | $ | 38,524 |
March 2023 Form 10-Q |
29
|
Risk Disclosures |
![]() |
Counterparty Credit Rating
1
|
||||||||||||||||||||
$ in millions | AAA | AA | A | BBB | NIG | Total | ||||||||||||||
At March 31, 2023 | ||||||||||||||||||||
Less than 1 year | $ | 2,071 | $ | 15,151 | $ | 32,023 | $ | 29,160 | $ | 9,933 | $ | 88,338 | ||||||||
1-3 years | 1,520 | 7,243 | 14,507 | 16,267 | 7,213 | 46,750 | ||||||||||||||
3-5 years | 633 | 6,542 | 7,117 | 8,750 | 3,196 | 26,238 | ||||||||||||||
Over 5 years | 3,959 | 39,743 | 38,447 | 37,361 | 6,011 | 125,521 | ||||||||||||||
Total, gross | $ | 8,183 | $ | 68,679 | $ | 92,094 | $ | 91,538 | $ | 26,353 | $ | 286,847 | ||||||||
Counterparty netting | (3,599) | (55,095) | (66,179) | (71,713) | (14,946) | (211,532) | ||||||||||||||
Cash and securities collateral | (2,929) | (11,078) | (22,797) | (13,729) | (5,456) | (55,989) | ||||||||||||||
Total, net | $ | 1,655 | $ | 2,506 | $ | 3,118 | $ | 6,096 | $ | 5,951 | $ | 19,326 |
Counterparty Credit Rating
1
|
||||||||||||||||||||
$ in millions | AAA | AA | A | BBB | NIG | Total | ||||||||||||||
At December 31, 2022 | ||||||||||||||||||||
Less than 1 year | $ | 2,903 | $ | 18,166 | $ | 40,825 | $ | 32,373 | $ | 10,730 | $ | 104,997 | ||||||||
1-3 years | 1,818 | 8,648 | 17,113 | 19,365 | 6,974 | 53,918 | ||||||||||||||
3-5 years | 655 | 6,834 | 8,632 | 9,105 | 4,049 | 29,275 | ||||||||||||||
Over 5 years | 4,206 | 42,613 | 45,488 | 46,660 | 8,244 | 147,211 | ||||||||||||||
Total, gross | $ | 9,582 | $ | 76,261 | $ | 112,058 | $ | 107,503 | $ | 29,997 | $ | 335,401 | ||||||||
Counterparty netting | (4,037) | (60,451) | (79,334) | (85,786) | (17,415) | (247,023) | ||||||||||||||
Cash and securities collateral | (3,632) | (13,402) | (28,776) | (14,457) | (5,198) | (65,465) | ||||||||||||||
Total, net | $ | 1,913 | $ | 2,408 | $ | 3,948 | $ | 7,260 | $ | 7,384 | $ | 22,913 |
$ in millions |
At
March 31, 2023 |
At
December 31, 2022 |
||||||
Industry | ||||||||
Financials | $ | 5,677 | $ | 6,294 | ||||
Utilities | 4,562 | 5,656 | ||||||
Regional governments | 1,839 | 2,052 | ||||||
Energy | 1,480 | 2,851 | ||||||
Industrials | 1,287 | 1,433 | ||||||
Communications services | 1,036 | 1,051 | ||||||
Consumer staples | 707 | 687 | ||||||
Healthcare | 509 | 565 | ||||||
Information technology | 468 | 480 | ||||||
Consumer Discretionary | 453 | 290 | ||||||
Materials | 310 | 317 | ||||||
Not-for-profit organizations | 214 | 204 | ||||||
Insurance | 174 | 185 | ||||||
Sovereign governments | 162 | 410 | ||||||
Real estate | 113 | 95 | ||||||
Other | 335 | 343 | ||||||
Total | $ | 19,326 | $ | 22,913 |
$ in millions | United Kingdom | Germany | Japan | France | Australia | ||||||||||||
Sovereign | |||||||||||||||||
Net inventory
1
|
$ | (419) | $ | (611) | $ | 300 | $ | 75 | $ | 132 | |||||||
Net counterparty exposure
2
|
10 | 118 | 196 | 12 | 88 | ||||||||||||
Exposure before hedges | (409) | (493) | 496 | 87 | 220 | ||||||||||||
Hedges
3
|
(56) | (273) | (187) | (6) | — | ||||||||||||
Net exposure | $ | (465) | $ | (766) | $ | 309 | $ | 81 | $ | 220 | |||||||
Non-sovereign | |||||||||||||||||
Net inventory
1
|
$ | 1,491 | $ | 190 | $ | 1,140 | $ | 17 | $ | 498 | |||||||
Net counterparty exposure
2
|
9,992 | 3,819 | 4,572 | 3,487 | 881 | ||||||||||||
Loans | 5,481 | 990 | 329 | 1,001 | 1,494 | ||||||||||||
Lending commitments | 6,760 | 4,108 | — | 2,742 | 1,084 | ||||||||||||
Exposure before hedges | 23,724 | 9,107 | 6,041 | 7,247 | 3,957 | ||||||||||||
Hedges
3
|
(2,026) | (1,706) | (625) | (2,210) | (297) | ||||||||||||
Net exposure | $ | 21,698 | $ | 7,401 | $ | 5,416 | $ | 5,037 | $ | 3,660 | |||||||
Total net exposure | $ | 21,233 | $ | 6,635 | $ | 5,725 | $ | 5,118 | $ | 3,880 |
$ in millions | Brazil | China | India | Canada | Spain | ||||||||||||
Sovereign | |||||||||||||||||
Net inventory
1
|
$ | 2,555 | $ | 290 | $ | 1,356 | $ | 242 | $ | 141 | |||||||
Net counterparty exposure
2
|
5 | 197 | — | 67 | 51 | ||||||||||||
Exposure before hedges | 2,560 | 487 | 1,356 | 309 | 192 | ||||||||||||
Hedges
3
|
(195) | (65) | — | — | (8) | ||||||||||||
Net exposure | $ | 2,365 | $ | 422 | $ | 1,356 | $ | 309 | $ | 184 | |||||||
Non-sovereign | |||||||||||||||||
Net inventory
1
|
$ | 167 | $ | 2,048 | $ | 1,028 | $ | 510 | $ | 305 | |||||||
Net counterparty exposure
2
|
574 | 188 | 1,006 | 1,094 | 375 | ||||||||||||
Loans | 308 | 568 | 135 | 382 | 2,171 | ||||||||||||
Lending commitments | 404 | 652 | — | 1,381 | 857 | ||||||||||||
Exposure before hedges | 1,453 | 3,456 | 2,169 | 3,367 | 3,708 | ||||||||||||
Hedges
3
|
(42) | (125) | — | (183) | (584) | ||||||||||||
Net exposure | $ | 1,411 | $ | 3,331 | $ | 2,169 | $ | 3,184 | $ | 3,124 | |||||||
Total net exposure | $ | 3,776 | $ | 3,753 | $ | 3,525 | $ | 3,493 | $ | 3,308 |
30
|
March 2023 Form 10-Q |
Risk Disclosures |
![]() |
$ in millions |
At
March 31, 2023 |
|||||||
Country of Risk |
Collateral
2
|
|||||||
United Kingdom | U.K., U.S. and France | $ | 8,122 | |||||
Germany | France, Spain, and Portugal | 6,442 | ||||||
Other | Japan, France, and Spain | 15,217 |
March 2023 Form 10-Q |
31
|
/s/ Deloitte & Touche LLP
|
||
New York, New York | ||
May 2, 2023 |
32
|
March 2023 Form 10-Q |
Consolidated Income Statement
(Unaudited) |
![]() |
Three Months Ended
March 31, |
||||||||||||||
in millions, except per share data | 2023 | 2022 | ||||||||||||
Revenues | ||||||||||||||
Investment banking | $ |
|
$ |
|
||||||||||
Trading |
|
|
||||||||||||
Investments |
|
|
||||||||||||
Commissions and fees |
|
|
||||||||||||
Asset management |
|
|
||||||||||||
Other |
|
|
||||||||||||
Total non-interest revenues |
|
|
||||||||||||
Interest income |
|
|
||||||||||||
Interest expense |
|
|
||||||||||||
Net interest |
|
|
||||||||||||
Net revenues |
|
|
||||||||||||
Provision for credit losses |
|
|
||||||||||||
Non-interest expenses | ||||||||||||||
Compensation and benefits |
|
|
||||||||||||
Brokerage, clearing and exchange fees |
|
|
||||||||||||
Information processing and communications |
|
|
||||||||||||
Professional services |
|
|
||||||||||||
Occupancy and equipment |
|
|
||||||||||||
Marketing and business development |
|
|
||||||||||||
Other |
|
|
||||||||||||
Total non-interest expenses |
|
|
||||||||||||
Income before provision for income taxes |
|
|
||||||||||||
Provision for income taxes |
|
|
||||||||||||
Net income | $ |
|
$ |
|
||||||||||
Net income applicable to noncontrolling interests |
|
|
||||||||||||
Net income applicable to Morgan Stanley | $ |
|
$ |
|
||||||||||
Preferred stock dividends |
|
|
||||||||||||
Earnings applicable to Morgan Stanley common shareholders | $ |
|
$ |
|
||||||||||
Earnings per common share | ||||||||||||||
Basic | $ |
|
$ |
|
||||||||||
Diluted | $ |
|
$ |
|
||||||||||
Average common shares outstanding | ||||||||||||||
Basic |
|
|
||||||||||||
Diluted |
|
|
Three Months Ended
March 31, |
||||||||||||||
$ in millions | 2023 | 2022 | ||||||||||||
Net income | $ |
|
$ |
|
||||||||||
Other comprehensive income (loss), net of tax: | ||||||||||||||
Foreign currency translation adjustments |
|
(
|
||||||||||||
Change in net unrealized gains (losses) on available-for-sale securities |
|
(
|
||||||||||||
Pension and other |
(
|
|
||||||||||||
Change in net debt valuation adjustment |
(
|
|
||||||||||||
Net change in cash flow hedges |
|
|
||||||||||||
Total other comprehensive income (loss) | $ |
|
$ |
(
|
||||||||||
Comprehensive income | $ |
|
$ |
|
||||||||||
Net income applicable to noncontrolling interests |
|
|
||||||||||||
Other comprehensive income (loss) applicable to noncontrolling interests |
(
|
(
|
||||||||||||
Comprehensive income applicable to Morgan Stanley | $ |
|
$ |
|
See Notes to Consolidated Financial Statements |
33
|
March 2023 Form 10-Q |
Consolidated Balance Sheet |
![]() |
$ in millions, except share data |
(Unaudited)
At
March 31, 2023 |
At
December 31, 2022 |
||||||
Assets | ||||||||
Cash and cash equivalents | $ |
|
$ |
|
||||
Trading assets at fair value (
$
|
|
|
||||||
Investment securities: | ||||||||
Available-for-sale at fair value (amortized cost of
$
|
|
|
||||||
Held-to-maturity (fair value of
$
|
|
|
||||||
Securities purchased under agreements to resell (includes
$
|
|
|
||||||
Securities borrowed |
|
|
||||||
Customer and other receivables |
|
|
||||||
Loans: | ||||||||
Held for investment (net of allowance for credit losses of
$
|
|
|
||||||
Held for sale |
|
|
||||||
Goodwill |
|
|
||||||
Intangible assets (net of accumulated amortization of
$
|
|
|
||||||
Other assets |
|
|
||||||
Total assets | $ |
|
$ |
|
||||
Liabilities | ||||||||
Deposits (includes
$
|
$ |
|
$ |
|
||||
Trading liabilities at fair value |
|
|
||||||
Securities sold under agreements to repurchase (includes
$
|
|
|
||||||
Securities loaned |
|
|
||||||
Other secured financings (includes
$
|
|
|
||||||
Customer and other payables |
|
|
||||||
Other liabilities and accrued expenses |
|
|
||||||
Borrowings (includes
$
|
|
|
||||||
Total liabilities |
|
|
||||||
Commitments and contingent liabilities (see Note 13) |
|
|
||||||
|
||||||||
Morgan Stanley shareholders’ equity: | ||||||||
Preferred stock |
|
|
||||||
Common stock, $
|
||||||||
Shares authorized:
|
|
|
||||||
Additional paid-in capital |
|
|
||||||
Retained earnings |
|
|
||||||
Employee stock trusts |
|
|
||||||
Accumulated other comprehensive income (loss) |
(
|
(
|
||||||
Common stock held in treasury at cost, $
|
(
|
(
|
||||||
Common stock issued to employee stock trusts |
(
|
(
|
||||||
Total Morgan Stanley shareholders’ equity |
|
|
||||||
Noncontrolling interests |
|
|
||||||
Total equity |
|
|
||||||
Total liabilities and equity | $ |
|
$ |
|
March 2023 Form 10-Q |
34
|
See Notes to Consolidated Financial Statements |
Consolidated Statement of Changes in Total Equity
(Unaudited) |
![]() |
Three Months Ended
March 31, |
||||||||||||||
$ in millions | 2023 | 2022 | ||||||||||||
Preferred Stock | ||||||||||||||
Beginning and ending balance | $ |
|
$ |
|
||||||||||
Common Stock | ||||||||||||||
Beginning and ending balance |
|
|
||||||||||||
Additional Paid-in Capital | ||||||||||||||
Beginning balance |
|
|
||||||||||||
Share-based award activity |
(
|
(
|
||||||||||||
Ending balance |
|
|
||||||||||||
Retained Earnings | ||||||||||||||
Beginning balance |
|
|
||||||||||||
Net income applicable to Morgan Stanley |
|
|
||||||||||||
Preferred stock dividends
1
|
(
|
(
|
||||||||||||
Common stock dividends
1
|
(
|
(
|
||||||||||||
Other net increases (decreases) |
(
|
|
||||||||||||
Ending balance |
|
|
||||||||||||
Employee Stock Trusts | ||||||||||||||
Beginning balance |
|
|
||||||||||||
Share-based award activity |
|
|
||||||||||||
Ending balance |
|
|
||||||||||||
Accumulated Other Comprehensive Income (Loss) | ||||||||||||||
Beginning balance |
(
|
(
|
||||||||||||
Net change in Accumulated other comprehensive income (loss) |
|
(
|
||||||||||||
Ending balance |
(
|
(
|
||||||||||||
Common Stock Held in Treasury at Cost | ||||||||||||||
Beginning balance |
(
|
(
|
||||||||||||
Share-based award activity |
|
|
||||||||||||
Repurchases of common stock and employee tax withholdings |
(
|
(
|
||||||||||||
Ending balance |
(
|
(
|
||||||||||||
Common Stock Issued to Employee Stock Trusts | ||||||||||||||
Beginning balance |
(
|
(
|
||||||||||||
Share-based award activity |
(
|
(
|
||||||||||||
Ending balance |
(
|
(
|
||||||||||||
Noncontrolling Interests | ||||||||||||||
Beginning balance |
|
|
||||||||||||
Net income applicable to noncontrolling interests |
|
|
||||||||||||
Net change in Accumulated other comprehensive income (loss) applicable to noncontrolling interests |
(
|
(
|
||||||||||||
Other net increases (decreases) |
|
|
||||||||||||
Ending balance |
|
|
||||||||||||
Total Equity | $ |
|
$ |
|
See Notes to Consolidated Financial Statements |
35
|
March 2023 Form 10-Q |
Consolidated Cash Flow Statement
(Unaudited) |
![]() |
Three Months Ended
March 31, |
||||||||
$ in millions | 2023 | 2022 | ||||||
Cash flows from operating activities | ||||||||
Net income | $ |
|
$ |
|
||||
Adjustments to reconcile net income to net cash provided by (used for) operating activities: | ||||||||
Stock-based compensation expense |
|
|
||||||
Depreciation and amortization |
|
|
||||||
Provision for credit losses |
|
|
||||||
Other operating adjustments |
|
|
||||||
Changes in assets and liabilities: | ||||||||
Trading assets, net of Trading liabilities |
|
|
||||||
Securities borrowed |
(
|
(
|
||||||
Securities loaned |
(
|
|
||||||
Customer and other receivables and other assets |
|
|
||||||
Customer and other payables and other liabilities |
|
|
||||||
Securities purchased under agreements to resell |
(
|
(
|
||||||
Securities sold under agreements to repurchase |
(
|
(
|
||||||
Net cash provided by (used for) operating activities |
(
|
|
||||||
Cash flows from investing activities | ||||||||
Proceeds from (payments for): | ||||||||
Other assets—Premises, equipment and software |
(
|
(
|
||||||
Changes in loans, net |
(
|
(
|
||||||
AFS securities
1
:
|
||||||||
Purchases |
(
|
(
|
||||||
Proceeds from sales |
|
|
||||||
Proceeds from paydowns and maturities |
|
|
||||||
HTM securities
1
:
|
||||||||
Purchases |
|
(
|
||||||
Proceeds from paydowns and maturities |
|
|
||||||
Other investing activities |
(
|
(
|
||||||
Net cash provided by (used for) investing activities |
(
|
|
||||||
Cash flows from financing activities | ||||||||
Net proceeds from (payments for): | ||||||||
Other secured financings |
|
(
|
||||||
Deposits |
(
|
|
||||||
Proceeds from issuance of Borrowings |
|
|
||||||
Payments for: | ||||||||
Borrowings |
(
|
(
|
||||||
Repurchases of common stock and employee tax withholdings |
(
|
(
|
||||||
Cash dividends |
(
|
(
|
||||||
Other financing activities |
|
(
|
||||||
Net cash provided by (used for) financing activities |
(
|
|
||||||
Effect of exchange rate changes on cash and cash equivalents |
|
(
|
||||||
Net increase (decrease) in cash and cash equivalents |
(
|
|
||||||
Cash and cash equivalents, at beginning of period |
|
|
||||||
Cash and cash equivalents, at end of period | $ |
|
$ |
|
||||
Supplemental Disclosure of Cash Flow Information | ||||||||
Cash payments for: | ||||||||
Interest | $ |
|
$ |
|
||||
Income taxes, net of refunds |
|
|
March 2023 Form 10-Q |
36
|
See Notes to Consolidated Financial Statements |
Notes to Consolidated Financial Statements
(Unaudited) |
![]() |
37
|
March 2023 Form 10-Q |
Notes to Consolidated Financial Statements
(Unaudited) |
![]() |
$ in millions |
At
March 31, 2023 |
At
December 31, 2022 |
||||||
Cash and due from banks | $ |
|
$ |
|
||||
Interest bearing deposits with banks |
|
|
||||||
Total Cash and cash equivalents | $ |
|
$ |
|
||||
Restricted cash | $ |
|
$ |
|
At March 31, 2023 | |||||||||||||||||
$ in millions | Level 1 | Level 2 | Level 3 |
Netting
1
|
Total | ||||||||||||
Assets at fair value | |||||||||||||||||
Trading assets: | |||||||||||||||||
U.S. Treasury and agency securities | $ |
|
$ |
|
$ |
|
$ | — | $ |
|
|||||||
Other sovereign government obligations |
|
|
|
— |
|
||||||||||||
State and municipal securities |
|
|
|
— |
|
||||||||||||
MABS |
|
|
|
— |
|
||||||||||||
Loans and lending commitments
2
|
|
|
|
— |
|
||||||||||||
Corporate and other debt |
|
|
|
— |
|
||||||||||||
Corporate equities
3
|
|
|
|
— |
|
||||||||||||
Derivative and other contracts: | |||||||||||||||||
Interest rate |
|
|
|
— |
|
||||||||||||
Credit |
|
|
|
— |
|
||||||||||||
Foreign exchange |
|
|
|
— |
|
||||||||||||
Equity |
|
|
|
— |
|
||||||||||||
Commodity and other |
|
|
|
— |
|
||||||||||||
Netting
1
|
(
|
(
|
(
|
(
|
(
|
||||||||||||
Total derivative and other contracts |
|
|
|
(
|
|
||||||||||||
Investments
4
|
|
|
|
— |
|
||||||||||||
Physical commodities |
|
|
|
— |
|
||||||||||||
Total trading assets
4
|
|
|
|
(
|
|
||||||||||||
Investment securities—AFS |
|
|
|
— |
|
||||||||||||
Securities purchased under agreements to resell |
|
|
|
— |
|
||||||||||||
Total assets at fair value | $ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
At March 31, 2023 | |||||||||||||||||
$ in millions | Level 1 | Level 2 | Level 3 |
Netting
1
|
Total | ||||||||||||
Liabilities at fair value | |||||||||||||||||
Deposits | $ |
|
$ |
|
$ |
|
$ | — | $ |
|
|||||||
Trading liabilities: | |||||||||||||||||
U.S. Treasury and agency securities |
|
|
|
— |
|
||||||||||||
Other sovereign government obligations |
|
|
|
— |
|
||||||||||||
Corporate and other debt |
|
|
|
— |
|
||||||||||||
Corporate equities
3
|
|
|
|
— |
|
||||||||||||
Derivative and other contracts: | |||||||||||||||||
Interest rate |
|
|
|
— |
|
||||||||||||
Credit |
|
|
|
— |
|
||||||||||||
Foreign exchange |
|
|
|
— |
|
||||||||||||
Equity |
|
|
|
— |
|
||||||||||||
Commodity and other |
|
|
|
— |
|
||||||||||||
Netting
1
|
(
|
(
|
(
|
(
|
(
|
||||||||||||
Total derivative and other contracts |
|
|
|
(
|
|
||||||||||||
Total trading liabilities |
|
|
|
(
|
|
||||||||||||
Securities sold under agreements to repurchase |
|
|
|
— |
|
||||||||||||
Other secured financings |
|
|
|
— |
|
||||||||||||
Borrowings |
|
|
|
— |
|
||||||||||||
Total liabilities at fair value | $ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
March 2023 Form 10-Q |
38
|
Notes to Consolidated Financial Statements
(Unaudited) |
![]() |
At December 31, 2022 | |||||||||||||||||
$ in millions | Level 1 | Level 2 | Level 3 |
Netting
1
|
Total | ||||||||||||
Assets at fair value | |||||||||||||||||
Trading assets: | |||||||||||||||||
U.S. Treasury and agency securities | $ |
|
$ |
|
$ |
|
$ | — | $ |
|
|||||||
Other sovereign government obligations |
|
|
|
— |
|
||||||||||||
State and municipal securities |
|
|
|
— |
|
||||||||||||
MABS |
|
|
|
— |
|
||||||||||||
Loans and lending commitments
2
|
|
|
|
— |
|
||||||||||||
Corporate and other debt |
|
|
|
— |
|
||||||||||||
Corporate equities
3
|
|
|
|
— |
|
||||||||||||
Derivative and other contracts: | |||||||||||||||||
Interest rate |
|
|
|
— |
|
||||||||||||
Credit |
|
|
|
— |
|
||||||||||||
Foreign exchange |
|
|
|
— |
|
||||||||||||
Equity |
|
|
|
— |
|
||||||||||||
Commodity and other |
|
|
|
— |
|
||||||||||||
Netting
1
|
(
|
(
|
(
|
(
|
(
|
||||||||||||
Total derivative and other contracts |
|
|
|
(
|
|
||||||||||||
Investments
4
|
|
|
|
— |
|
||||||||||||
Physical commodities |
|
|
|
— |
|
||||||||||||
Total trading assets
4
|
|
|
|
(
|
|
||||||||||||
Investment securities—AFS |
|
|
|
— |
|
||||||||||||
Securities purchased under agreements to resell |
|
|
|
— |
|
||||||||||||
Total assets at fair value | $ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
At December 31, 2022 | |||||||||||||||||
$ in millions | Level 1 | Level 2 | Level 3 |
Netting
1
|
Total | ||||||||||||
Liabilities at fair value | |||||||||||||||||
Deposits | $ |
|
$ |
|
$ |
|
$ | — | $ |
|
|||||||
Trading liabilities: | |||||||||||||||||
U.S. Treasury and agency securities |
|
|
|
— |
|
||||||||||||
Other sovereign government obligations |
|
|
|
— |
|
||||||||||||
Corporate and other debt |
|
|
|
— |
|
||||||||||||
Corporate equities
3
|
|
|
|
— |
|
||||||||||||
Derivative and other contracts: | |||||||||||||||||
Interest rate |
|
|
|
— |
|
||||||||||||
Credit |
|
|
|
— |
|
||||||||||||
Foreign exchange |
|
|
|
— |
|
||||||||||||
Equity |
|
|
|
— |
|
||||||||||||
Commodity and other |
|
|
|
— |
|
||||||||||||
Netting
1
|
(
|
(
|
(
|
(
|
(
|
||||||||||||
Total derivative and other contracts |
|
|
|
(
|
|
||||||||||||
Total trading liabilities |
|
|
|
(
|
|
||||||||||||
Securities sold under agreements to repurchase |
|
|
|
— |
|
||||||||||||
Other secured financings |
|
|
|
— |
|
||||||||||||
Borrowings |
|
|
|
— |
|
||||||||||||
Total liabilities at fair value | $ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ in millions |
At
March 31, 2023 |
At
December 31, 2022 |
||||||
Secured lending facilities | $ |
|
$ |
|
||||
Commercial Real Estate |
|
|
||||||
Residential Real Estate |
|
|
||||||
Securities-based lending and Other loans |
|
|
||||||
Total | $ |
|
$ |
|
$ in millions |
At
March 31, 2023 |
At
December 31, 2022 |
||||||
Customer and other receivables (payables), net | $ |
|
$ |
|
39
|
March 2023 Form 10-Q |
Notes to Consolidated Financial Statements
(Unaudited) |
![]() |
Three Months Ended
March 31, |
||||||||||||||
$ in millions | 2023 | 2022 | ||||||||||||
U.S. Treasury and agency securities | ||||||||||||||
Beginning balance | $ |
|
$ |
|
||||||||||
Purchases |
|
|
||||||||||||
Sales |
(
|
|
||||||||||||
Net transfers |
(
|
|
||||||||||||
Ending balance | $ |
|
$ |
|
||||||||||
Unrealized gains (losses) | $ |
|
$ |
|
||||||||||
Other sovereign government obligations | ||||||||||||||
Beginning balance | $ |
|
$ |
|
||||||||||
Realized and unrealized gains (losses) |
|
|
||||||||||||
Purchases |
|
|
||||||||||||
Sales |
(
|
(
|
||||||||||||
Net transfers |
(
|
|
||||||||||||
Ending balance | $ |
|
$ |
|
||||||||||
Unrealized gains (losses) | $ |
|
$ |
|
||||||||||
State and municipal securities | ||||||||||||||
Beginning balance | $ |
|
$ |
|
||||||||||
Sales |
(
|
|
||||||||||||
Net transfers |
(
|
(
|
||||||||||||
Ending balance | $ |
|
$ |
|
||||||||||
Unrealized gains (losses) | $ |
|
$ |
|
||||||||||
MABS | ||||||||||||||
Beginning balance | $ |
|
$ |
|
||||||||||
Realized and unrealized gains (losses) |
|
(
|
||||||||||||
Purchases |
|
|
||||||||||||
Sales |
(
|
(
|
||||||||||||
Net transfers |
|
|
||||||||||||
Ending balance | $ |
|
$ |
|
||||||||||
Unrealized gains (losses) | $ |
|
$ |
(
|
||||||||||
Loans and lending commitments | ||||||||||||||
Beginning balance | $ |
|
$ |
|
||||||||||
Realized and unrealized gains (losses) |
(
|
|
||||||||||||
Purchases and originations |
|
|
||||||||||||
Sales |
(
|
(
|
||||||||||||
Settlements |
(
|
(
|
||||||||||||
Net transfers |
(
|
(
|
||||||||||||
Ending balance | $ |
|
$ |
|
||||||||||
Unrealized gains (losses) | $ |
(
|
$ |
|
||||||||||
Corporate and other debt | ||||||||||||||
Beginning balance | $ |
|
$ |
|
||||||||||
Realized and unrealized gains (losses) |
|
|
||||||||||||
Purchases and originations |
|
|
||||||||||||
Sales |
(
|
(
|
||||||||||||
Net transfers |
|
(
|
||||||||||||
Ending balance | $ |
|
$ |
|
||||||||||
Unrealized gains (losses) | $ |
|
$ |
|
||||||||||
Corporate equities | ||||||||||||||
Beginning balance | $ |
|
$ |
|
||||||||||
Realized and unrealized gains (losses) |
(
|
|
||||||||||||
Purchases |
|
|
||||||||||||
Sales |
(
|
(
|
||||||||||||
Net transfers |
|
|
||||||||||||
Ending balance | $ |
|
$ |
|
||||||||||
Unrealized gains (losses) | $ |
(
|
$ |
|
Three Months Ended
March 31, |
||||||||||||||
$ in millions | 2023 | 2022 | ||||||||||||
Investments | ||||||||||||||
Beginning balance | $ |
|
$ |
|
||||||||||
Realized and unrealized gains (losses) |
|
(
|
||||||||||||
Purchases |
|
|
||||||||||||
Sales |
(
|
(
|
||||||||||||
Net transfers |
(
|
|
||||||||||||
Ending balance | $ |
|
$ |
|
||||||||||
Unrealized gains (losses) | $ |
|
$ |
(
|
||||||||||
Investment securities—AFS | ||||||||||||||
Beginning balance | $ |
|
$ |
|
||||||||||
Realized and unrealized gains (losses) |
|
|
||||||||||||
Net transfers |
(
|
|
||||||||||||
Ending balance | $ |
|
$ |
|
||||||||||
Unrealized gains (losses) | $ |
|
$ |
|
||||||||||
Net derivatives: Interest rate | ||||||||||||||
Beginning balance | $ |
(
|
$ |
|
||||||||||
Realized and unrealized gains (losses) |
(
|
|
||||||||||||
Purchases |
|
|
||||||||||||
Issuances |
(
|
(
|
||||||||||||
Settlements |
|
(
|
||||||||||||
Net transfers |
(
|
(
|
||||||||||||
Ending balance | $ |
(
|
$ |
|
||||||||||
Unrealized gains (losses) | $ |
|
$ |
|
||||||||||
Net derivatives: Credit | ||||||||||||||
Beginning balance | $ |
|
$ |
|
||||||||||
Realized and unrealized gains (losses) |
(
|
|
||||||||||||
Purchases |
|
|
||||||||||||
Issuances |
|
(
|
||||||||||||
Settlements |
(
|
(
|
||||||||||||
Net transfers |
(
|
|
||||||||||||
Ending balance | $ |
|
$ |
|
||||||||||
Unrealized gains (losses) | $ |
(
|
$ |
|
||||||||||
Net derivatives: Foreign exchange | ||||||||||||||
Beginning balance | $ |
|
$ |
|
||||||||||
Realized and unrealized gains (losses) |
(
|
(
|
||||||||||||
Purchases |
|
|
||||||||||||
Issuances |
(
|
|
||||||||||||
Settlements |
|
|
||||||||||||
Net transfers |
(
|
(
|
||||||||||||
Ending balance | $ |
|
$ |
(
|
||||||||||
Unrealized gains (losses) | $ |
(
|
$ |
(
|
||||||||||
Net derivatives: Equity | ||||||||||||||
Beginning balance | $ |
(
|
$ |
(
|
||||||||||
Realized and unrealized gains (losses) |
|
|
||||||||||||
Purchases |
|
|
||||||||||||
Issuances |
(
|
(
|
||||||||||||
Settlements |
(
|
|
||||||||||||
Net transfers |
|
|
||||||||||||
Ending balance | $ |
(
|
$ |
(
|
||||||||||
Unrealized gains (losses) | $ |
(
|
$ |
|
March 2023 Form 10-Q |
40
|
Notes to Consolidated Financial Statements
(Unaudited) |
![]() |
Three Months Ended
March 31, |
||||||||||||||
$ in millions | 2023 | 2022 | ||||||||||||
Net derivatives: Commodity and other | ||||||||||||||
Beginning balance | $ |
|
$ |
|
||||||||||
Realized and unrealized gains (losses) |
|
|
||||||||||||
Purchases |
|
|
||||||||||||
Issuances |
(
|
(
|
||||||||||||
Settlements |
(
|
(
|
||||||||||||
Net transfers |
|
(
|
||||||||||||
Ending balance | $ |
|
$ |
|
||||||||||
Unrealized gains (losses) | $ |
|
$ |
(
|
||||||||||
Deposits | ||||||||||||||
Beginning balance | $ |
|
$ |
|
||||||||||
Issuances |
|
|
||||||||||||
Settlements |
|
(
|
||||||||||||
Net transfers |
|
(
|
||||||||||||
Ending balance | $ |
|
$ |
|
||||||||||
Unrealized losses (gains) | $ |
|
$ |
|
||||||||||
Nonderivative trading liabilities | ||||||||||||||
Beginning balance | $ |
|
$ |
|
||||||||||
Realized and unrealized losses (gains) |
(
|
(
|
||||||||||||
Purchases |
(
|
(
|
||||||||||||
Sales |
|
|
||||||||||||
Net transfers |
|
|
||||||||||||
Ending balance | $ |
|
$ |
|
||||||||||
Unrealized losses (gains) | $ |
(
|
$ |
(
|
||||||||||
Securities sold under agreements to repurchase | ||||||||||||||
Beginning balance | $ |
|
$ |
|
||||||||||
Realized and unrealized losses (gains) |
|
|
||||||||||||
Settlements |
(
|
(
|
||||||||||||
Net transfers |
|
(
|
||||||||||||
Ending balance | $ |
|
$ |
|
||||||||||
Unrealized losses (gains) | $ |
|
$ |
|
||||||||||
Other secured financings | ||||||||||||||
Beginning balance | $ |
|
$ |
|
||||||||||
Realized and unrealized losses (gains) |
|
(
|
||||||||||||
Issuances |
|
|
||||||||||||
Settlements |
(
|
(
|
||||||||||||
Net transfers |
|
(
|
||||||||||||
Ending balance | $ |
|
$ |
|
||||||||||
Unrealized losses (gains) | $ |
|
$ |
(
|
||||||||||
Borrowings | ||||||||||||||
Beginning balance | $ |
|
$ |
|
||||||||||
Realized and unrealized losses (gains) |
|
(
|
||||||||||||
Issuances |
|
|
||||||||||||
Settlements |
(
|
(
|
||||||||||||
Net transfers |
(
|
|
||||||||||||
Ending balance | $ |
|
$ |
|
||||||||||
Unrealized losses (gains) | $ |
|
$ |
(
|
||||||||||
Portion of Unrealized losses (gains) recorded in OCI—Change in net DVA |
|
(
|
Balance / Range (Average
1
)
|
||||||||
$ in millions, except inputs | At March 31, 2023 | At December 31, 2022 | ||||||
Assets at Fair Value on a Recurring Basis | ||||||||
Other sovereign government obligations | $ |
|
$ |
|
||||
Comparable pricing: | ||||||||
Bond price |
|
|
||||||
State and municipal securities | $ |
|
$ |
|
||||
Comparable pricing: | ||||||||
Bond price | N/M |
|
||||||
MABS | $ |
|
$ |
|
||||
Comparable pricing: | ||||||||
Bond price |
|
|
||||||
Loans and lending
commitments |
$ |
|
$ |
|
||||
Margin loan model: | ||||||||
Margin loan rate |
|
|
||||||
Comparable pricing: | ||||||||
Loan price |
|
|
||||||
Corporate and
other debt |
$ |
|
$ |
|
||||
Comparable pricing: | ||||||||
Bond price |
|
|
||||||
Discounted cash flow: | ||||||||
Loss given default |
|
|
||||||
Corporate equities | $ |
|
$ |
|
||||
Comparable pricing: | ||||||||
Equity price |
|
|
||||||
Investments | $ |
|
$ |
|
||||
Discounted cash flow: | ||||||||
WACC |
|
|
||||||
Exit multiple |
|
|
||||||
Market approach: | ||||||||
EBITDA multiple |
|
|
||||||
Comparable pricing: | ||||||||
Equity price |
|
|
||||||
41
|
March 2023 Form 10-Q |
Notes to Consolidated Financial Statements
(Unaudited) |
![]() |
Balance / Range (Average
1
)
|
||||||||
$ in millions, except inputs | At March 31, 2023 | At December 31, 2022 | ||||||
Net derivative and other contracts: | ||||||||
Interest rate | $ |
(
|
$ |
(
|
||||
Option model: | ||||||||
IR volatility skew |
|
|
||||||
IR curve correlation |
|
|
||||||
Bond volatility |
|
N/M | ||||||
Inflation volatility |
|
|
||||||
IR curve |
|
|
||||||
Credit | $ |
|
$ |
|
||||
Credit default swap model: | ||||||||
Cash-synthetic basis |
|
|
||||||
Bond price |
|
|
||||||
Credit spread |
|
|
||||||
Funding spread |
|
|
||||||
Foreign exchange
2
|
$ |
|
$ |
|
||||
Option model: | ||||||||
IR curve |
-
|
-
|
||||||
Foreign exchange volatility skew |
-
|
|
||||||
Contingency probability |
|
|
||||||
Equity
2
|
$ |
(
|
$ |
(
|
||||
Option model: | ||||||||
Equity volatility |
|
|
||||||
Equity volatility skew |
-
|
-
|
||||||
Equity correlation |
|
|
||||||
FX correlation |
-
|
-
|
||||||
IR correlation |
|
|
||||||
Commodity and other | $ |
|
$ |
|
||||
Option model: | ||||||||
Forward power price |
$
|
$
|
||||||
Commodity volatility |
|
|
||||||
Cross-commodity correlation |
|
|
||||||
Liabilities Measured at Fair Value on a Recurring Basis | ||||||||
Securities sold under agreements to repurchase | $ |
|
$ |
|
||||
Discounted cash flow: | ||||||||
Funding spread |
|
|
||||||
Other secured financings | $ |
|
$ |
|
||||
Comparable pricing: | ||||||||
Loan price |
|
|
||||||
Balance / Range (Average
1
)
|
||||||||
$ in millions, except inputs | At March 31, 2023 | At December 31, 2022 | ||||||
Borrowings | $ |
|
$ |
|
||||
Option model: | ||||||||
Equity volatility |
|
|
||||||
Equity volatility skew |
-
|
-
|
||||||
Equity correlation |
|
|
||||||
Equity - FX correlation |
-
|
-
|
||||||
IR curve correlation |
|
N/M | ||||||
IR volatility skew | N/M |
|
||||||
Discounted cash flow: | ||||||||
Loss given default |
|
|
||||||
Nonrecurring Fair Value Measurement | ||||||||
Loans | $ |
|
$ |
|
||||
Corporate loan model: | ||||||||
Credit spread |
|
|
||||||
Comparable pricing: | ||||||||
Loan price |
|
|
||||||
Warehouse model: | ||||||||
Credit spread |
|
|
||||||
March 2023 Form 10-Q |
42
|
Notes to Consolidated Financial Statements
(Unaudited) |
![]() |
At March 31, 2023 | At December 31, 2022 | |||||||||||||
$ in millions |
Carrying
Value |
Commitment |
Carrying
Value |
Commitment | ||||||||||
Private equity | $ |
|
$ |
|
$ |
|
$ |
|
||||||
Real estate |
|
|
|
|
||||||||||
Hedge
1
|
|
|
|
|
||||||||||
Total | $ |
|
$ |
|
$ |
|
$ |
|
Carrying Value at March 31, 2023 | ||||||||
$ in millions | Private Equity | Real Estate | ||||||
Less than 5 years | $ |
|
$ |
|
||||
5-10 years |
|
|
||||||
Over 10 years |
|
|
||||||
Total | $ |
|
$ |
|
At March 31, 2023 | |||||||||||
Fair Value | |||||||||||
$ in millions | Level 2 |
Level 3
1
|
Total | ||||||||
Assets | |||||||||||
Loans | $ |
|
$ |
|
$ |
|
|||||
Other assets—Other investments |
|
|
|
||||||||
Other assets—ROU assets |
|
|
|
||||||||
Total | $ |
|
$ |
|
$ |
|
|||||
Liabilities | |||||||||||
Other liabilities and accrued expenses—Lending commitments | $ |
|
$ |
|
$ |
|
|||||
Total | $ |
|
$ |
|
$ |
|
At December 31, 2022 | |||||||||||
Fair Value | |||||||||||
$ in millions | Level 2 |
Level 3
1
|
Total | ||||||||
Assets | |||||||||||
Loans | $ |
|
$ |
|
$ |
|
|||||
Other assets—Other investments |
|
|
|
||||||||
Other assets—ROU assets |
|
|
|
||||||||
Total | $ |
|
$ |
|
$ |
|
|||||
Liabilities | |||||||||||
Other liabilities and accrued expenses—Lending commitments | $ |
|
$ |
|
$ |
|
|||||
Total | $ |
|
$ |
|
$ |
|
Three Months Ended
March 31, |
||||||||||||||
$ in millions | 2023 | 2022 | ||||||||||||
Assets | ||||||||||||||
Loans
2
|
$ |
|
$ |
(
|
||||||||||
Other assets—Other investments
3
|
|
(
|
||||||||||||
Other assets—Premises, equipment and software
4
|
(
|
(
|
||||||||||||
Other assets—ROU assets
5
|
|
(
|
||||||||||||
Total | $ |
|
$ |
(
|
||||||||||
Liabilities | ||||||||||||||
Other liabilities and accrued expenses—Lending commitments
2
|
$ |
|
$ |
(
|
||||||||||
Total | $ |
|
$ |
(
|
43
|
March 2023 Form 10-Q |
Notes to Consolidated Financial Statements
(Unaudited) |
![]() |
At March 31, 2023 | |||||||||||||||||
Carrying
Value |
Fair Value | ||||||||||||||||
$ in millions | Level 1 | Level 2 | Level 3 | Total | |||||||||||||
Financial assets | |||||||||||||||||
Cash and cash equivalents | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||
Investment securities—HTM |
|
|
|
|
|
||||||||||||
Securities purchased under agreements to resell |
|
|
|
|
|
||||||||||||
Securities borrowed |
|
|
|
|
|
||||||||||||
Customer and other receivables |
|
|
|
|
|
||||||||||||
Loans
1
|
|
|
|
|
|
||||||||||||
Other assets |
|
|
|
|
|
||||||||||||
Financial liabilities | |||||||||||||||||
Deposits | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||
Securities sold under agreements to repurchase |
|
|
|
|
|
||||||||||||
Securities loaned |
|
|
|
|
|
||||||||||||
Other secured financings |
|
|
|
|
|
||||||||||||
Customer and other payables |
|
|
|
|
|
||||||||||||
Borrowings |
|
|
|
|
|
||||||||||||
Commitment
Amount |
|||||||||||||||||
Lending commitments
2
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
At December 31, 2022 | |||||||||||||||||
Carrying
Value |
Fair Value | ||||||||||||||||
$ in millions | Level 1 | Level 2 | Level 3 | Total | |||||||||||||
Financial assets | |||||||||||||||||
Cash and cash equivalents | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||
Investment securities—HTM |
|
|
|
|
|
||||||||||||
Securities purchased under agreements to resell |
|
|
|
|
|
||||||||||||
Securities borrowed |
|
|
|
|
|
||||||||||||
Customer and other receivables |
|
|
|
|
|
||||||||||||
Loans
1
|
|
|
|
|
|
||||||||||||
Other assets |
|
|
|
|
|
||||||||||||
Financial liabilities | |||||||||||||||||
Deposits | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||
Securities sold under agreements to repurchase |
|
|
|
|
|
||||||||||||
Securities loaned |
|
|
|
|
|
||||||||||||
Other secured financings |
|
|
|
|
|
||||||||||||
Customer and other payables |
|
|
|
|
|
||||||||||||
Borrowings |
|
|
|
|
|
||||||||||||
Commitment
Amount |
|||||||||||||||||
Lending commitments
2
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ in millions |
At
March 31, 2023 |
At
December 31, 2022 |
||||||
Business Unit Responsible for Risk Management | ||||||||
Equity | $ |
|
$ |
|
||||
Interest rates |
|
|
||||||
Commodities |
|
|
||||||
Credit |
|
|
||||||
Foreign exchange |
|
|
||||||
Total | $ |
|
$ |
|
Three Months Ended
March 31, |
||||||||||||||
$ in millions | 2023 | 2022 | ||||||||||||
Trading revenues | $ |
(
|
$ |
|
||||||||||
Interest expense |
|
|
||||||||||||
Net revenues
1
|
$ |
(
|
$ |
|
Three Months Ended March 31, | ||||||||||||||
2023 | 2022 | |||||||||||||
$ in millions |
Trading
Revenues |
OCI |
Trading
Revenues |
OCI | ||||||||||
Loans and other receivables
1
|
$ |
(
|
$ |
|
$ |
|
$ |
|
||||||
Lending commitments |
|
|
|
|
||||||||||
Deposits |
|
|
|
(
|
||||||||||
Borrowings |
(
|
(
|
|
|
$ in millions |
At
March 31, 2023 |
At
December 31, 2022 |
||||||
Cumulative pre-tax DVA gain (loss) recognized in AOCI | $ |
(
|
$ |
(
|
March 2023 Form 10-Q |
44
|
Notes to Consolidated Financial Statements
(Unaudited) |
![]() |
$ in millions |
At
March 31, 2023 |
At
December 31, 2022 |
||||||
Loans and other receivables
2
|
$ |
|
$ |
|
||||
Nonaccrual loans
2
|
|
|
||||||
Borrowings
3
|
|
|
$ in millions |
At
March 31, 2023 |
At
December 31, 2022 |
||||||
Nonaccrual loans | $ |
|
$ |
|
||||
Nonaccrual loans 90 or more days past due |
|
|
Assets at March 31, 2023 | ||||||||||||||
$ in millions | Bilateral OTC | Cleared OTC | Exchange-Traded | Total | ||||||||||
Designated as accounting hedges | ||||||||||||||
Interest rate | $ |
|
$ |
|
$ |
|
$ |
|
||||||
Foreign exchange |
|
|
|
|
||||||||||
Total |
|
|
|
|
||||||||||
Not designated as accounting hedges | ||||||||||||||
Economic hedges of loans | ||||||||||||||
Credit |
|
|
|
|
||||||||||
Other derivatives | ||||||||||||||
Interest rate |
|
|
|
|
||||||||||
Credit |
|
|
|
|
||||||||||
Foreign exchange |
|
|
|
|
||||||||||
Equity |
|
|
|
|
||||||||||
Commodity and other |
|
|
|
|
||||||||||
Total |
|
|
|
|
||||||||||
Total gross derivatives | $ |
|
$ |
|
$ |
|
$ |
|
||||||
Amounts offset | ||||||||||||||
Counterparty netting |
(
|
(
|
(
|
(
|
||||||||||
Cash collateral netting |
(
|
(
|
|
(
|
||||||||||
Total in Trading assets | $ |
|
$ |
|
$ |
|
$ |
|
||||||
Amounts not offset
1
|
||||||||||||||
Financial instruments collateral |
(
|
|
|
(
|
||||||||||
Net amounts | $ |
|
$ |
|
$ |
|
$ |
|
||||||
Net amounts for which master netting or collateral agreements are not in place or may not be legally enforceable | $ |
|
Liabilities at March 31, 2023 | ||||||||||||||
$ in millions | Bilateral OTC | Cleared OTC | Exchange-Traded | Total | ||||||||||
Designated as accounting hedges | ||||||||||||||
Interest rate | $ |
|
$ |
|
$ |
|
$ |
|
||||||
Foreign exchange |
|
|
|
|
||||||||||
Total |
|
|
|
|
||||||||||
Not designated as accounting hedges | ||||||||||||||
Economic hedges of loans | ||||||||||||||
Credit |
|
|
|
|
||||||||||
Other derivatives | ||||||||||||||
Interest rate |
|
|
|
|
||||||||||
Credit |
|
|
|
|
||||||||||
Foreign exchange |
|
|
|
|
||||||||||
Equity |
|
|
|
|
||||||||||
Commodity and other |
|
|
|
|
||||||||||
Total |
|
|
|
|
||||||||||
Total gross derivatives | $ |
|
$ |
|
$ |
|
$ |
|
||||||
Amounts offset | ||||||||||||||
Counterparty netting |
(
|
(
|
(
|
(
|
||||||||||
Cash collateral netting |
(
|
(
|
|
(
|
||||||||||
Total in Trading liabilities | $ |
|
$ |
|
$ |
|
$ |
|
||||||
Amounts not offset
1
|
||||||||||||||
Financial instruments collateral |
(
|
|
(
|
(
|
||||||||||
Net amounts | $ |
|
$ |
|
$ |
|
$ |
|
||||||
Net amounts for which master netting or collateral agreements are not in place or may not be legally enforceable |
|
Assets at December 31, 2022 | ||||||||||||||
$ in millions | Bilateral OTC | Cleared OTC | Exchange-Traded | Total | ||||||||||
Designated as accounting hedges | ||||||||||||||
Interest rate | $ |
|
$ |
|
$ |
|
$ |
|
||||||
Foreign exchange |
|
|
|
|
||||||||||
Total |
|
|
|
|
||||||||||
Not designated as accounting hedges | ||||||||||||||
Economic hedges of loans | ||||||||||||||
Credit |
|
|
|
|
||||||||||
Other derivatives | ||||||||||||||
Interest rate |
|
|
|
|
||||||||||
Credit |
|
|
|
|
||||||||||
Foreign exchange |
|
|
|
|
||||||||||
Equity |
|
|
|
|
||||||||||
Commodity and other |
|
|
|
|
||||||||||
Total |
|
|
|
|
||||||||||
Total gross derivatives | $ |
|
$ |
|
$ |
|
$ |
|
||||||
Amounts offset | ||||||||||||||
Counterparty netting |
(
|
(
|
(
|
(
|
||||||||||
Cash collateral netting |
(
|
(
|
|
(
|
||||||||||
Total in Trading assets | $ |
|
$ |
|
$ |
|
$ |
|
||||||
Amounts not offset
1
|
||||||||||||||
Financial instruments collateral |
(
|
|
|
(
|
||||||||||
Net amounts | $ |
|
$ |
|
$ |
|
$ |
|
||||||
Net amounts for which master netting or collateral agreements are not in place or may not be legally enforceable | $ |
|
45
|
March 2023 Form 10-Q |
Notes to Consolidated Financial Statements
(Unaudited) |
![]() |
Liabilities at December 31, 2022 | ||||||||||||||
$ in millions | Bilateral OTC | Cleared OTC | Exchange-Traded | Total | ||||||||||
Designated as accounting hedges | ||||||||||||||
Interest rate | $ |
|
$ |
|
$ |
|
$ |
|
||||||
Foreign exchange |
|
|
|
|
||||||||||
Total |
|
|
|
|
||||||||||
Not designated as accounting hedges | ||||||||||||||
Economic hedges of loans | ||||||||||||||
Credit |
|
|
|
|
||||||||||
Other derivatives | ||||||||||||||
Interest rate |
|
|
|
|
||||||||||
Credit |
|
|
|
|
||||||||||
Foreign exchange |
|
|
|
|
||||||||||
Equity |
|
|
|
|
||||||||||
Commodity and other |
|
|
|
|
||||||||||
Total |
|
|
|
|
||||||||||
Total gross derivatives | $ |
|
$ |
|
$ |
|
$ |
|
||||||
Amounts offset | ||||||||||||||
Counterparty netting |
(
|
(
|
(
|
(
|
||||||||||
Cash collateral netting |
(
|
(
|
|
(
|
||||||||||
Total in Trading liabilities | $ |
|
$ |
|
$ |
|
$ |
|
||||||
Amounts not offset
1
|
||||||||||||||
Financial instruments collateral |
(
|
|
(
|
(
|
||||||||||
Net amounts | $ |
|
$ |
|
$ |
|
$ |
|
||||||
Net amounts for which master netting or collateral agreements are not in place or may not be legally enforceable | $ |
|
Assets at March 31, 2023 | ||||||||||||||
$ in billions | Bilateral OTC | Cleared OTC | Exchange- Traded | Total | ||||||||||
Designated as accounting hedges | ||||||||||||||
Interest rate | $ |
|
$ |
|
$ |
|
$ |
|
||||||
Foreign exchange |
|
|
|
|
||||||||||
Total |
|
|
|
|
||||||||||
Not designated as accounting hedges | ||||||||||||||
Economic hedges of loans | ||||||||||||||
Credit |
|
|
|
|
||||||||||
Other derivatives | ||||||||||||||
Interest rate |
|
|
|
|
||||||||||
Credit |
|
|
|
|
||||||||||
Foreign exchange |
|
|
|
|
||||||||||
Equity |
|
|
|
|
||||||||||
Commodity and other |
|
|
|
|
||||||||||
Total |
|
|
|
|
||||||||||
Total gross derivatives | $ |
|
$ |
|
$ |
|
$ |
|
Liabilities at March 31, 2023 | ||||||||||||||
$ in billions | Bilateral OTC | Cleared OTC | Exchange- Traded | Total | ||||||||||
Designated as accounting hedges | ||||||||||||||
Interest rate | $ |
|
$ |
|
$ |
|
$ |
|
||||||
Foreign exchange |
|
|
|
|
||||||||||
Total |
|
|
|
|
||||||||||
Not designated as accounting hedges | ||||||||||||||
Economic hedges of loans | ||||||||||||||
Credit |
|
|
|
|
||||||||||
Other derivatives | ||||||||||||||
Interest rate |
|
|
|
|
||||||||||
Credit |
|
|
|
|
||||||||||
Foreign exchange |
|
|
|
|
||||||||||
Equity |
|
|
|
|
||||||||||
Commodity and other |
|
|
|
|
||||||||||
Total |
|
|
|
|
||||||||||
Total gross derivatives | $ |
|
$ |
|
$ |
|
$ |
|
Assets at December 31, 2022 | ||||||||||||||
$ in billions | Bilateral OTC | Cleared OTC | Exchange-Traded | Total | ||||||||||
Designated as accounting hedges | ||||||||||||||
Interest rate | $ |
|
$ |
|
$ |
|
$ |
|
||||||
Foreign exchange |
|
|
|
|
||||||||||
Total |
|
|
|
|
||||||||||
Not designated as accounting hedges | ||||||||||||||
Economic hedges of loans | ||||||||||||||
Credit |
|
|
|
|
||||||||||
Other derivatives | ||||||||||||||
Interest rate |
|
|
|
|
||||||||||
Credit |
|
|
|
|
||||||||||
Foreign exchange |
|
|
|
|
||||||||||
Equity |
|
|
|
|
||||||||||
Commodity and other |
|
|
|
|
||||||||||
Total |
|
|
|
|
||||||||||
Total gross derivatives | $ |
|
$ |
|
$ |
|
$ |
|
Liabilities at December 31, 2022 | ||||||||||||||
$ in billions | Bilateral OTC | Cleared OTC | Exchange-Traded | Total | ||||||||||
Designated as accounting hedges | ||||||||||||||
Interest rate | $ |
|
$ |
|
$ |
|
$ |
|
||||||
Foreign exchange |
|
|
|
|
||||||||||
Total |
|
|
|
|
||||||||||
Not designated as accounting hedges | ||||||||||||||
Economic hedges of loans | ||||||||||||||
Credit |
|
|
|
|
||||||||||
Other derivatives | ||||||||||||||
Interest rate |
|
|
|
|
||||||||||
Credit |
|
|
|
|
||||||||||
Foreign exchange |
|
|
|
|
||||||||||
Equity |
|
|
|
|
||||||||||
Commodity and other |
|
|
|
|
||||||||||
Total |
|
|
|
|
||||||||||
Total gross derivatives | $ |
|
$ |
|
$ |
|
$ |
|
March 2023 Form 10-Q |
46
|
Notes to Consolidated Financial Statements
(Unaudited) |
![]() |
Three Months Ended | ||||||||||||||
March 31, | ||||||||||||||
$ in millions | 2023 | 2022 | ||||||||||||
Fair value hedges—Recognized in Interest income | ||||||||||||||
Interest rate contracts | $ |
(
|
$ |
|
||||||||||
Investment Securities—AFS |
|
(
|
||||||||||||
Fair value hedges—Recognized in Interest expense | ||||||||||||||
Interest rate contracts | $ |
|
$ |
(
|
||||||||||
Deposits |
(
|
|
||||||||||||
Borrowings |
(
|
|
||||||||||||
Net investment hedges—Foreign exchange contracts | ||||||||||||||
Recognized in OCI | $ |
(
|
$ |
|
||||||||||
Forward points excluded from hedge effectiveness testing—Recognized in Interest income |
|
(
|
||||||||||||
Cash flow hedges—Interest rate contracts
1
|
||||||||||||||
Recognized in OCI | $ |
|
$ |
|
||||||||||
Less: Realized gains (losses) (pre-tax) reclassified from AOCI to interest income |
(
|
|
||||||||||||
Net change in cash flow hedges included within AOCI |
|
|
$ in millions |
At
March 31, 2023 |
At
December 31, 2022 |
||||||
Investment Securities—AFS | ||||||||
Amortized cost basis currently or previously hedged | $ |
|
$ |
|
||||
Basis adjustments included in amortized cost
1
|
$ |
(
|
$ |
(
|
||||
Deposits | ||||||||
Carrying amount
currently or previously hedged
|
$ |
|
$ |
|
||||
Basis adjustments included in carrying amount
1
|
$ |
(
|
$ |
(
|
||||
Borrowings | ||||||||
Carrying amount
currently or previously hedged
|
$ |
|
$ |
|
||||
Basis adjustments included in carrying amount
—
Outstanding hedges
|
$ |
(
|
$ |
(
|
||||
Basis adjustments included in carrying amount
—
Terminated hedges
|
$ |
(
|
$ |
(
|
Three Months Ended | ||||||||||||||
March 31, | ||||||||||||||
$ in millions | 2023 | 2022 | ||||||||||||
Recognized in Other revenues | ||||||||||||||
Credit contracts
1
|
$ |
(
|
$ |
|
$ in millions |
At
March 31, 2023 |
At
December 31, 2022 |
||||||
Net derivative liabilities with credit risk-related contingent features | $ |
|
$ |
|
||||
Collateral posted |
|
|
$ in millions |
At
March 31, 2023 |
||||
One-notch downgrade | $ |
|
|||
Two-notch downgrade |
|
||||
Bilateral downgrade agreements included in the amounts above
1
|
$ |
|
Years to Maturity at March 31, 2023 | |||||||||||||||||
$ in billions | < 1 | 1-3 | 3-5 | Over 5 | Total | ||||||||||||
Single-name CDS | |||||||||||||||||
Investment grade | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||
Non-investment grade |
|
|
|
|
|
||||||||||||
Total | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||
Index and basket CDS | |||||||||||||||||
Investment grade | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||
Non-investment grade |
|
|
|
|
|
||||||||||||
Total | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||
Total CDS sold | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||
Other credit contracts |
|
|
|
|
|
||||||||||||
Total credit protection sold | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||
CDS protection sold with identical protection purchased | $ |
|
47
|
March 2023 Form 10-Q |
Notes to Consolidated Financial Statements
(Unaudited) |
![]() |
Years to Maturity at December 31, 2022 | |||||||||||||||||
$ in billions | < 1 | 1-3 | 3-5 | Over 5 | Total | ||||||||||||
Single-name CDS | |||||||||||||||||
Investment grade | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||
Non-investment grade |
|
|
|
|
|
||||||||||||
Total | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||
Index and basket CDS | |||||||||||||||||
Investment grade | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||
Non-investment grade |
|
|
|
|
|
||||||||||||
Total | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||
Total CDS sold | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||
Other credit contracts |
|
|
|
|
|
||||||||||||
Total credit protection sold | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||
CDS protection sold with identical protection purchased | $ |
|
$ in millions |
At
March 31, 2023 |
At
December 31, 2022 |
||||||
Single-name CDS | ||||||||
Investment grade | $ |
|
$ |
|
||||
Non-investment grade |
(
|
(
|
||||||
Total | $ |
|
$ |
(
|
||||
Index and basket CDS | ||||||||
Investment grade | $ |
|
$ |
|
||||
Non-investment grade |
(
|
(
|
||||||
Total | $ |
(
|
$ |
(
|
||||
Total CDS sold | $ |
(
|
$ |
(
|
||||
Other credit contracts |
|
(
|
||||||
Total credit protection sold | $ |
(
|
$ |
(
|
Notional | ||||||||
$ in billions |
At
March 31, 2023 |
At
December 31, 2022 |
||||||
Single name | $ |
|
$ |
|
||||
Index and basket |
|
|
||||||
Tranched index and basket |
|
|
||||||
Total | $ |
|
$ |
|
Fair Value Asset (Liability) | ||||||||
$ in millions |
At
March 31, 2023 |
At
December 31, 2022 |
||||||
Single name | $ |
(
|
$ |
(
|
||||
Index and basket |
|
|
||||||
Tranched index and basket |
(
|
(
|
||||||
Total | $ |
|
$ |
|
At March 31, 2023 | ||||||||||||||
$ in millions |
Amortized Cost
1
|
Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | ||||||||||
AFS securities | ||||||||||||||
U.S. Treasury securities | $ |
|
$ |
|
$ |
|
$ |
|
||||||
U.S. agency securities
2
|
|
|
|
|
||||||||||
Agency CMBS |
|
|
|
|
||||||||||
State and municipal securities |
|
|
|
|
||||||||||
FFELP student loan ABS
3
|
|
|
|
|
||||||||||
Total AFS securities |
|
|
|
|
||||||||||
HTM securities | ||||||||||||||
U.S. Treasury securities |
|
|
|
|
||||||||||
U.S. agency securities
2
|
|
|
|
|
||||||||||
Agency CMBS |
|
|
|
|
||||||||||
Non-agency CMBS |
|
|
|
|
||||||||||
Total HTM securities |
|
|
|
|
||||||||||
Total investment securities | $ |
|
$ |
|
$ |
|
$ |
|
At December 31, 2022 | ||||||||||||||
$ in millions |
Amortized Cost
1
|
Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | ||||||||||
AFS securities | ||||||||||||||
U.S. Treasury securities | $ |
|
$ |
|
$ |
|
$ |
|
||||||
U.S. agency securities
2
|
|
|
|
|
||||||||||
Agency CMBS |
|
|
|
|
||||||||||
Non-agency CMBS |
|
|
|
|
||||||||||
Corporate bonds |
|
|
|
|
||||||||||
State and municipal securities |
|
|
|
|
||||||||||
FFELP student loan ABS
3
|
|
|
|
|
||||||||||
Total AFS securities |
|
|
|
|
||||||||||
HTM securities | ||||||||||||||
U.S. Treasury securities |
|
|
|
|
||||||||||
U.S. agency securities
2
|
|
|
|
|
||||||||||
Agency CMBS |
|
|
|
|
||||||||||
Non-agency CMBS |
|
|
|
|
||||||||||
Total HTM securities |
|
|
|
|
||||||||||
Total investment securities | $ |
|
$ |
|
$ |
|
$ |
|
March 2023 Form 10-Q |
48
|
Notes to Consolidated Financial Statements
(Unaudited) |
![]() |
At
March 31, 2023 |
At
December 31, 2022 |
|||||||||||||
$ in millions | Fair Value | Gross Unrealized Losses | Fair Value | Gross Unrealized Losses | ||||||||||
U.S. Treasury securities | ||||||||||||||
Less than 12 months | $ |
|
$ |
|
$ |
|
$ |
|
||||||
12 months or longer |
|
|
|
|
||||||||||
Total |
|
|
|
|
||||||||||
U.S. agency securities | ||||||||||||||
Less than 12 months |
|
|
|
|
||||||||||
12 months or longer |
|
|
|
|
||||||||||
Total |
|
|
|
|
||||||||||
Agency CMBS | ||||||||||||||
Less than 12 months |
|
|
|
|
||||||||||
12 months or longer |
|
|
|
|
||||||||||
Total |
|
|
|
|
||||||||||
State and municipal securities | ||||||||||||||
Less than 12 months |
|
|
|
|
||||||||||
12 months or longer |
|
|
|
|
||||||||||
Total |
|
|
|
|
||||||||||
FFELP student loan ABS | ||||||||||||||
Less than 12 months |
|
|
|
|
||||||||||
12 months or longer |
|
|
|
|
||||||||||
Total |
|
|
|
|
||||||||||
Total AFS securities in an unrealized loss position | ||||||||||||||
Less than 12 months |
|
|
|
|
||||||||||
12 months or longer |
|
|
|
|
||||||||||
Total | $ |
|
$ |
|
$ |
|
$ |
|
At March 31, 2023 | |||||||||||
$ in millions |
Amortized Cost
1
|
Fair Value |
Annualized Average Yield
2,3
|
||||||||
AFS securities | |||||||||||
U.S. Treasury securities: | |||||||||||
Due within 1 year | $ |
|
$ |
|
|
% | |||||
After 1 year through 5 years |
|
|
|
% | |||||||
After 5 years through 10 years |
|
|
|
% | |||||||
Total |
|
|
|||||||||
U.S. agency securities: | |||||||||||
Due within 1 year |
|
|
(
|
% | |||||||
After 1 year through 5 years |
|
|
|
% | |||||||
After 5 years through 10 years |
|
|
|
% | |||||||
After 10 years |
|
|
|
% | |||||||
Total |
|
|
|||||||||
Agency CMBS: | |||||||||||
After 1 year through 5 years |
|
|
|
% | |||||||
After 5 years through 10 years |
|
|
|
% | |||||||
After 10 years |
|
|
|
% | |||||||
Total |
|
|
|||||||||
State and municipal securities: | |||||||||||
Due within 1 year |
|
|
|
% | |||||||
After 1 year through 5 years |
|
|
|
% | |||||||
After 5 years through 10 years |
|
|
|
% | |||||||
After 10 Years |
|
|
|
% | |||||||
Total |
|
|
|||||||||
FFELP student loan ABS: | |||||||||||
After 1 year through 5 years |
|
|
|
% | |||||||
After 5 years through 10 years |
|
|
|
% | |||||||
After 10 years |
|
|
|
% | |||||||
Total |
|
|
|||||||||
Total AFS securities |
|
|
|
% | |||||||
49
|
March 2023 Form 10-Q |
Notes to Consolidated Financial Statements
(Unaudited) |
![]() |
At March 31, 2023 | |||||||||||
$ in millions |
Amortized Cost
1
|
Fair Value |
Annualized Average Yield
2
|
||||||||
HTM securities | |||||||||||
U.S. Treasury securities: | |||||||||||
Due within 1 year |
|
|
|
% | |||||||
After 1 year through 5 years |
|
|
|
% | |||||||
After 5 years through 10 years |
|
|
|
% | |||||||
After 10 years |
|
|
|
% | |||||||
Total |
|
|
|||||||||
U.S. agency securities: | |||||||||||
After 1 year through 5 years |
|
|
|
% | |||||||
After 5 years through 10 years |
|
|
|
% | |||||||
After 10 years |
|
|
|
% | |||||||
Total |
|
|
|||||||||
Agency CMBS: | |||||||||||
Due within 1 year |
|
|
|
% | |||||||
After 1 year through 5 years |
|
|
|
% | |||||||
After 5 years through 10 years |
|
|
|
% | |||||||
After 10 years |
|
|
|
% | |||||||
Total |
|
|
|||||||||
Non-agency CMBS: | |||||||||||
Due within 1 year |
|
|
|
% | |||||||
After 1 year through 5 years |
|
|
|
% | |||||||
After 5 years through 10 years |
|
|
|
% | |||||||
After 10 years |
|
|
|
% | |||||||
Total |
|
|
|||||||||
Total HTM securities |
|
|
|
% | |||||||
Total investment securities |
|
|
|
% |
Three Months Ended
March 31, |
||||||||||||||
$ in millions | 2023 | 2022 | ||||||||||||
Gross realized gains | $ |
|
$ |
|
||||||||||
Gross realized (losses) |
(
|
(
|
||||||||||||
Total
1
|
$ |
|
$ |
|
At March 31, 2023 | |||||||||||||||||
$ in millions | Gross Amounts | Amounts Offset | Balance Sheet Net Amounts |
Amounts Not Offset
1
|
Net Amounts | ||||||||||||
Assets | |||||||||||||||||
Securities purchased under agreements to resell | $ |
|
$ |
(
|
$ |
|
$ |
(
|
$ |
|
|||||||
Securities borrowed |
|
(
|
|
(
|
|
||||||||||||
Liabilities | |||||||||||||||||
Securities sold under agreements to repurchase | $ |
|
$ |
(
|
$ |
|
$ |
(
|
$ |
|
|||||||
Securities loaned |
|
(
|
|
(
|
|
||||||||||||
Net amounts for which master netting agreements are not in place or may not be legally enforceable | |||||||||||||||||
Securities purchased under agreements to resell | $ |
|
|||||||||||||||
Securities borrowed |
|
||||||||||||||||
Securities sold under agreements to repurchase |
|
||||||||||||||||
Securities loaned |
|
At December 31, 2022 | |||||||||||||||||
$ in millions | Gross Amounts | Amounts Offset | Balance Sheet Net Amounts |
Amounts Not Offset
1
|
Net Amounts | ||||||||||||
Assets | |||||||||||||||||
Securities purchased under agreements to resell | $ |
|
$ |
(
|
$ |
|
$ |
(
|
$ |
|
|||||||
Securities borrowed |
|
(
|
|
(
|
|
||||||||||||
Liabilities | |||||||||||||||||
Securities sold under agreements to repurchase | $ |
|
$ |
(
|
$ |
|
$ |
(
|
$ |
|
|||||||
Securities loaned |
|
(
|
|
(
|
|
||||||||||||
Net amounts for which master netting agreements are not in place or may not be legally enforceable | |||||||||||||||||
Securities purchased under agreements to resell | $ |
|
|||||||||||||||
Securities borrowed |
|
||||||||||||||||
Securities sold under agreements to repurchase |
|
||||||||||||||||
Securities loaned |
|
At March 31, 2023 | |||||||||||||||||
$ in millions | Overnight and Open | Less than 30 Days | 30-90 Days | Over 90 Days | Total | ||||||||||||
Securities sold under agreements to repurchase | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||
Securities loaned |
|
|
|
|
|
||||||||||||
Total included in the offsetting disclosure | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||
Trading liabilities—
Obligation to return securities received as collateral |
|
|
|
|
|
||||||||||||
Total | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
March 2023 Form 10-Q |
50
|
Notes to Consolidated Financial Statements
(Unaudited) |
![]() |
At December 31, 2022 | |||||||||||||||||
$ in millions | Overnight and Open | Less than 30 Days | 30-90 Days | Over 90 Days | Total | ||||||||||||
Securities sold under agreements to repurchase | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||
Securities loaned |
|
|
|
|
|
||||||||||||
Total included in the offsetting disclosure | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||
Trading liabilities—
Obligation to return securities received as collateral |
|
|
|
|
|
||||||||||||
Total | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ in millions |
At
March 31, 2023 |
At
December 31, 2022 |
||||||
Securities sold under agreements to repurchase | ||||||||
U.S. Treasury and agency securities | $ |
|
$ |
|
||||
Other sovereign government obligations |
|
|
||||||
Corporate equities |
|
|
||||||
Other |
|
|
||||||
Total | $ |
|
$ |
|
||||
Securities loaned | ||||||||
Other sovereign government obligations | $ |
|
$ |
|
||||
Corporate equities |
|
|
||||||
Other |
|
|
||||||
Total | $ |
|
$ |
|
||||
Total included in the offsetting disclosure | $ |
|
$ |
|
||||
Trading liabilities—Obligation to return securities received as collateral | ||||||||
Corporate equities | $ |
|
$ |
|
||||
Other |
|
|
||||||
Total | $ |
|
$ |
|
||||
Total | $ |
|
$ |
|
$ in millions |
At
March 31, 2023 |
At
December 31, 2022 |
|||||||||
$ |
|
$ |
|
||||||||
$ in millions |
At
March 31, 2023 |
At
December 31, 2022 |
||||||
Collateral received with right to sell or repledge | $ |
|
$ |
|
||||
Collateral that was sold or repledged
1
|
|
|
$ in millions |
At
March 31, 2023 |
At
December 31, 2022 |
||||||
Segregated securities
1
|
$ |
|
$ |
|
$ in millions |
At
March 31, 2023 |
At
December 31, 2022 |
||||||
Margin and other lending | $ |
|
$ |
|
51
|
March 2023 Form 10-Q |
Notes to Consolidated Financial Statements
(Unaudited) |
![]() |
At March 31, 2023 | |||||||||||
$ in millions | HFI Loans | HFS Loans | Total Loans | ||||||||
Corporate | $ |
|
$ |
|
$ |
|
|||||
Secured lending facilities |
|
|
|
||||||||
Commercial real estate |
|
|
|
||||||||
Residential real estate |
|
|
|
||||||||
Securities-based lending and Other loans |
|
|
|
||||||||
Total loans |
|
|
|
||||||||
ACL |
(
|
(
|
|||||||||
Total loans, net | $ |
|
$ |
|
$ |
|
|||||
Loans to non-U.S. borrowers, net | $ |
|
At December 31, 2022 | |||||||||||
$ in millions | HFI Loans | HFS Loans | Total Loans | ||||||||
Corporate | $ |
|
$ |
|
$ |
|
|||||
Secured lending facilities |
|
|
|
||||||||
Commercial real estate |
|
|
|
||||||||
Residential real estate |
|
|
|
||||||||
Securities-based lending and Other loans |
|
|
|
||||||||
Total loans |
|
|
|
||||||||
ACL |
(
|
(
|
|||||||||
Total loans, net | $ |
|
$ |
|
$ |
|
|||||
Loans to non-U.S. borrowers, net | $ |
|
At March 31, 2023 | At December 31, 2022 | |||||||||||||
$ in millions | Fixed Rate | Floating or Adjustable Rate | Fixed Rate | Floating or Adjustable Rate | ||||||||||
Corporate | $ |
|
$ |
|
$ |
|
$ |
|
||||||
Secured lending facilities |
|
|
|
|
||||||||||
Commercial real estate |
|
|
|
|
||||||||||
Residential real estate |
|
|
|
|
||||||||||
Securities-based lending and Other loans |
|
|
|
|
||||||||||
Total loans, before ACL | $ |
|
$ |
|
$ |
|
$ |
|
At March 31, 2023 | At December 31, 2022 | |||||||||||||||||||
Corporate | ||||||||||||||||||||
$ in millions | IG | NIG | Total | IG | NIG | Total | ||||||||||||||
Revolving
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||
2023 |
|
|
|
|||||||||||||||||
2022 |
|
|
|
|
|
|
||||||||||||||
2021 |
|
|
|
|
|
|
||||||||||||||
2020 |
|
|
|
|
|
|
||||||||||||||
2019 |
|
|
|
|
|
|
||||||||||||||
Prior
|
|
|
|
|
|
|
||||||||||||||
Total
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
At March 31, 2023 | At December 31, 2022 | |||||||||||||||||||
Secured Lending Facilities | ||||||||||||||||||||
$ in millions | IG | NIG | Total | IG | NIG | Total | ||||||||||||||
Revolving
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||
2023 |
|
|
|
|||||||||||||||||
2022 |
|
|
|
|
|
|
||||||||||||||
2021 |
|
|
|
|
|
|
||||||||||||||
2020 |
|
|
|
|
|
|
||||||||||||||
2019 |
|
|
|
|
|
|
||||||||||||||
Prior
|
|
|
|
|
|
|
||||||||||||||
Total
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
At March 31, 2023 | At December 31, 2022 | |||||||||||||||||||
Commercial Real Estate | ||||||||||||||||||||
$ in millions | IG | NIG | Total | IG | NIG | Total | ||||||||||||||
Revolving
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||
2023 |
|
|
|
|||||||||||||||||
2022 |
|
|
|
|
|
|
||||||||||||||
2021 |
|
|
|
|
|
|
||||||||||||||
2020 |
|
|
|
|
|
|
||||||||||||||
2019 |
|
|
|
|
|
|
||||||||||||||
Prior
|
|
|
|
|
|
|
||||||||||||||
Total
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
At March 31, 2023 | ||||||||||||||||||||||||||
Residential Real Estate | ||||||||||||||||||||||||||
by FICO Scores | by LTV Ratio | Total | ||||||||||||||||||||||||
$ in millions | ≥ 740 | 680-739 | ≤ 679 | ≤ 80% | > 80% | |||||||||||||||||||||
Revolving | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||
2023 |
|
|
|
|
|
|
||||||||||||||||||||
2022 |
|
|
|
|
|
|
||||||||||||||||||||
2021 |
|
|
|
|
|
|
||||||||||||||||||||
2020 |
|
|
|
|
|
|
||||||||||||||||||||
2019 |
|
|
|
|
|
|
||||||||||||||||||||
Prior |
|
|
|
|
|
|
||||||||||||||||||||
Total | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
At December 31, 2022 | ||||||||||||||||||||||||||
Residential Real Estate | ||||||||||||||||||||||||||
by FICO Scores | by LTV Ratio | Total | ||||||||||||||||||||||||
$ in millions | ≥ 740 | 680-739 | ≤ 679 | ≤ 80% | > 80% | |||||||||||||||||||||
Revolving | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||
2022 |
|
|
|
|
|
|
||||||||||||||||||||
2021 |
|
|
|
|
|
|
||||||||||||||||||||
2020 |
|
|
|
|
|
|
||||||||||||||||||||
2019 |
|
|
|
|
|
|
||||||||||||||||||||
2018 |
|
|
|
|
|
|
||||||||||||||||||||
Prior |
|
|
|
|
|
|
||||||||||||||||||||
Total | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
March 2023 Form 10-Q |
52
|
Notes to Consolidated Financial Statements
(Unaudited) |
![]() |
At March 31, 2023 | ||||||||||||||
Securities-based Lending
1
|
Other
2
|
|||||||||||||
$ in millions | IG | NIG | Total | |||||||||||
Revolving | $ |
|
$ |
|
$ |
|
$ |
|
||||||
2023 |
|
|
|
|
||||||||||
2022 |
|
|
|
|
||||||||||
2021 |
|
|
|
|
||||||||||
2020 |
|
|
|
|
||||||||||
2019 |
|
|
|
|
||||||||||
Prior |
|
|
|
|
||||||||||
Total | $ |
|
$ |
|
$ |
|
$ |
|
December 31, 2022 | ||||||||||||||
Securities-based Lending
1
|
Other
2
|
|||||||||||||
$ in millions | IG | NIG | Total | |||||||||||
Revolving | $ |
|
$ |
|
$ |
|
$ |
|
||||||
2022 |
|
|
|
|
||||||||||
2021 |
|
|
|
|
||||||||||
2020 |
|
|
|
|
||||||||||
2019 |
|
|
|
|
||||||||||
2018 |
|
|
|
|
||||||||||
Prior |
|
|
|
|
||||||||||
Total | $ |
|
$ |
|
$ |
|
$ |
|
$ in millions | At March 31, 2023 | At December 31, 2022 | ||||||
Corporate | $ |
|
$ |
|
||||
Secured lending facilities |
|
|
||||||
Residential real estate |
|
|
||||||
Securities-based lending and Other loans |
|
|
||||||
Total | $ |
|
$ |
|
$ in millions | At March 31, 2023 | At December 31, 2022 | ||||||
Corporate | $ |
|
$ |
|
||||
Secured lending facilities |
|
|
||||||
Commercial real estate |
|
|
||||||
Residential real estate |
|
|
||||||
Securities-based lending and Other loans |
|
|
||||||
Total
1
|
$ |
|
$ |
|
||||
Nonaccrual loans without an ACL | $ |
|
$ |
|
At March 31, 2023
2
|
||||||||
$ in millions | Amortized Cost |
% of Total Loans
3
|
||||||
Term Extension | ||||||||
Corporate | $ |
|
|
% | ||||
Commercial real estate |
|
|
% | |||||
Residential real estate |
|
|
% | |||||
Total | $ |
|
||||||
Other-than-insignificant Payment Delay | ||||||||
Commercial real estate | $ |
|
|
% | ||||
At March 31, 2023 | |||||
Term Extension | |||||
Corporate |
Added a weighted-average
|
||||
Commercial real estate |
Added a weighted-average
|
||||
Residential real estate |
Added
|
||||
Other-than-insignificant Payment Delay | |||||
Commercial real estate |
Provided a forbearance period of
|
||||
$ in millions | At December 31, 2022 | ||||||||||
Loans, before ACL | $ |
|
|||||||||
Allowance for credit losses |
|
Three Months Ended March 31, 2023 | ||||||||||||||||||||
$ in millions | Corporate | Secured Lending Facilities | CRE | Residential Real Estate | SBL and Other | Total | ||||||||||||||
Revolving
|
$ |
(
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
||||||||
2019 |
|
|
(
|
|
(
|
(
|
||||||||||||||
Prior
|
|
|
(
|
|
|
(
|
||||||||||||||
Total
|
$ |
(
|
$ |
|
$ |
(
|
$ |
|
$ |
(
|
$ |
(
|
53
|
March 2023 Form 10-Q |
Notes to Consolidated Financial Statements
(Unaudited) |
![]() |
$ in millions | Corporate | Secured Lending Facilities | CRE | Residential Real Estate | SBL and Other | Total | ||||||||||||||
December 31, 2022 | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||
Gross charge-offs |
(
|
|
(
|
|
(
|
(
|
||||||||||||||
Provision (release) |
|
|
|
|
|
|
||||||||||||||
Other |
|
(
|
|
|
|
|
||||||||||||||
March 31, 2023 | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||
Percent of loans to total loans
1
|
|
% |
|
% |
|
% |
|
% |
|
% |
|
% |
$ in millions | Corporate | Secured Lending Facilities | CRE | Residential Real Estate | SBL and Other | Total | ||||||||||||||
December 31, 2021 | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||
Gross charge-offs |
|
(
|
(
|
|
(
|
(
|
||||||||||||||
Provision (release) |
|
|
|
|
|
|
||||||||||||||
Other |
(
|
|
(
|
|
|
(
|
||||||||||||||
March 31, 2022 | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||
Percent of loans to total loans
1
|
|
% |
|
% |
|
% |
|
% |
|
% |
|
% |
$ in millions | Corporate | Secured Lending Facilities | CRE | Residential Real Estate | SBL and Other | Total | ||||||||||||||
December 31, 2022 | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||
Provision (release) |
|
|
|
|
|
|
||||||||||||||
Other |
|
|
|
|
|
|
||||||||||||||
March 31, 2023 | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ in millions | Corporate | Secured Lending Facilities | CRE | Residential Real Estate | SBL and Other | Total | ||||||||||||||
December 31, 2021 | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||
Provision (release) |
|
|
(
|
|
(
|
|
||||||||||||||
Other |
(
|
|
|
|
|
(
|
||||||||||||||
March 31, 2022 | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
At
March 31, 2023 |
At
December 31, 2022 |
|||||||
ACL for loans to total HFI loans |
|
% |
|
% | ||||
Nonaccrual HFI loans to total HFI loans
1
|
|
% |
|
% | ||||
ACL for loans to nonaccrual HFI loans
|
|
% |
|
% |
$ in millions |
At
March 31, 2023 |
At
December 31, 2022 |
||||||
Currently employed by the Firm
1
|
$ |
|
$ |
|
||||
No longer employed by the Firm
2
|
|
|
||||||
Employee loans | $ |
|
$ |
|
||||
ACL |
(
|
(
|
||||||
Employee loans, net of ACL | $ |
|
$ |
|
||||
Remaining repayment term, weighted average in years |
|
|
$ in millions |
At
March 31, 2023 |
At
December 31, 2022 |
||||||
Investments | $ |
|
$ |
|
Three Months Ended
March 31, |
||||||||||||||
$ in millions | 2023 | 2022 | ||||||||||||
Income (loss) | $ |
|
$ |
|
Three Months Ended
March 31, |
||||||||||||||
$ in millions | 2023 | 2022 | ||||||||||||
Income (loss) from investment in MUMSS | $ |
|
$ |
|
March 2023 Form 10-Q |
54
|
Notes to Consolidated Financial Statements
(Unaudited) |
![]() |
$ in millions |
At
March 31, 2023 |
At
December 31, 2022 |
||||||
Savings and demand deposits | $ |
|
$ |
|
||||
Time deposits |
|
|
||||||
Total | $ |
|
$ |
|
||||
Deposits subject to FDIC insurance | $ |
|
$ |
|
||||
Deposits not subject to FDIC insurance | $ |
|
$ |
|
||||
$ in millions |
At
March 31, 2023 |
||||
2023 | $ |
|
|||
2024 |
|
||||
2025 |
|
||||
2026 |
|
||||
2027 |
|
||||
Thereafter |
|
||||
Total | $ |
|
$ in millions |
At
March 31, 2023 |
At
December 31, 2022 |
||||||
Original maturities of one year or less | $ |
|
$ |
|
||||
Original maturities greater than one year | ||||||||
Senior | $ |
|
$ |
|
||||
Subordinated |
|
|
||||||
Total | $ |
|
$ |
|
||||
Total borrowings | $ |
|
$ |
|
||||
Weighted average stated maturity, in years
1
|
|
|
$ in millions |
At
March 31, 2023 |
At
December 31, 2022 |
||||||
Original maturities: | ||||||||
One year or less | $ |
|
$ |
|
||||
Greater than one year |
|
|
||||||
Total | $ |
|
$ |
|
||||
Transfers of assets accounted for as secured financings | $ |
|
$ |
|
Years to Maturity at March 31, 2023 | |||||||||||||||||
$ in millions | Less than 1 | 1-3 | 3-5 | Over 5 | Total | ||||||||||||
Lending: | |||||||||||||||||
Corporate | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||
Secured lending facilities |
|
|
|
|
|
||||||||||||
Commercial and Residential real estate |
|
|
|
|
|
||||||||||||
Securities-based lending and Other |
|
|
|
|
|
||||||||||||
Forward-starting secured financing receivables
1
|
|
|
|
|
|
||||||||||||
Central counterparty |
|
|
|
|
|
||||||||||||
Underwriting |
|
|
|
|
|
||||||||||||
Investment activities |
|
|
|
|
|
||||||||||||
Letters of credit and other financial guarantees |
|
|
|
|
|
||||||||||||
Total | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||
Lending commitments participated to third parties | $ |
|
|||||||||||||||
At March 31, 2023 | ||||||||||||||||||||
Maximum Potential Payout/Notional of Obligations by Years to Maturity
|
Carrying Amount Asset (Liability) | |||||||||||||||||||
$ in millions | Less than 1 | 1-3 | 3-5 | Over 5 | ||||||||||||||||
Non-credit derivatives
1
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
||||||||||
Standby letters of credit and other financial guarantees issued
2
|
|
|
|
|
(
|
|||||||||||||||
Market value guarantees |
|
|
|
|
|
|||||||||||||||
Liquidity facilities |
|
|
|
|
(
|
|||||||||||||||
Whole loan sales guarantees |
|
|
|
|
|
|||||||||||||||
Securitization representations and warranties
3
|
|
|
|
|
(
|
|||||||||||||||
General partner guarantees |
|
|
|
|
(
|
|||||||||||||||
Client clearing guarantees |
|
|
|
|
|
55
|
March 2023 Form 10-Q |
Notes to Consolidated Financial Statements
(Unaudited) |
![]() |
Three Months Ended
March 31, |
||||||||||||||
$ in millions | 2023 | 2022 | ||||||||||||
Legal expenses | $ |
|
$ |
|
March 2023 Form 10-Q |
56
|
Notes to Consolidated Financial Statements
(Unaudited) |
![]() |
At March 31, 2023 | At December 31, 2022 | |||||||||||||
$ in millions | VIE Assets | VIE Liabilities | VIE Assets | VIE Liabilities | ||||||||||
MABS
1
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||
Investment vehicles
2
|
|
|
|
|
||||||||||
MTOB |
|
|
|
|
||||||||||
Other |
|
|
|
|
||||||||||
Total | $ |
|
$ |
|
$ |
|
$ |
|
57
|
March 2023 Form 10-Q |
Notes to Consolidated Financial Statements
(Unaudited) |
![]() |
$ in millions |
At
March 31, 2023 |
At
December 31, 2022 |
||||||
Assets | ||||||||
Cash and cash equivalents | $ |
|
$ |
|
||||
Trading assets at fair value |
|
|
||||||
Investment securities |
|
|
||||||
Securities purchased under agreements to resell |
|
|
||||||
Customer and other receivables |
|
|
||||||
Other assets |
|
|
||||||
Total | $ |
|
$ |
|
||||
Liabilities | ||||||||
Other secured financings | $ |
|
$ |
|
||||
Other liabilities and accrued expenses |
|
|
||||||
Borrowings |
|
|
||||||
Total | $ |
|
$ |
|
||||
Noncontrolling interests | $ |
|
$ |
|
At March 31, 2023 | |||||||||||||||||
$ in millions |
MABS
1
|
CDO | MTOB | OSF |
Other
2
|
||||||||||||
VIE assets (UPB) | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||
Maximum exposure to loss
3
|
|||||||||||||||||
Debt and equity interests | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||
Derivative and other contracts |
|
|
|
|
|
||||||||||||
Commitments, guarantees and other |
|
|
|
|
|
||||||||||||
Total | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||
Carrying value of variable interests—Assets | |||||||||||||||||
Debt and equity interests | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||
Derivative and other contracts |
|
|
|
|
|
||||||||||||
Total | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||
Additional VIE assets owned
4
|
$ |
|
|||||||||||||||
Carrying value of variable interests—Liabilities | |||||||||||||||||
Derivative and other contracts | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||
At December 31, 2022 | |||||||||||||||||
$ in millions |
MABS
1
|
CDO | MTOB | OSF |
Other
2
|
||||||||||||
VIE assets (UPB) | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||
Maximum exposure to loss
3
|
|||||||||||||||||
Debt and equity interests | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||
Derivative and other contracts |
|
|
|
|
|
||||||||||||
Commitments, guarantees and other |
|
|
|
|
|
||||||||||||
Total | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||
Carrying value of variable interests
–
Assets
|
|||||||||||||||||
Debt and equity interests | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||
Derivative and other contracts |
|
|
|
|
|
||||||||||||
Total | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||
Additional VIE assets owned
4
|
$ |
|
|||||||||||||||
Carrying value of variable interests—Liabilities | |||||||||||||||||
Derivative and other contracts | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
At March 31, 2023 | At December 31, 2022 | |||||||||||||
$ in millions | UPB | Debt and Equity Interests | UPB | Debt and Equity Interests | ||||||||||
Residential mortgages | $ |
|
$ |
|
$ |
|
$ |
|
||||||
Commercial mortgages |
|
|
|
|
||||||||||
U.S. agency collateralized mortgage obligations |
|
|
|
|
||||||||||
Other consumer or commercial loans |
|
|
|
|
||||||||||
Total | $ |
|
$ |
|
$ |
|
$ |
|
March 2023 Form 10-Q |
58
|
Notes to Consolidated Financial Statements
(Unaudited) |
![]() |
At March 31, 2023 | ||||||||||||||
$ in millions | RML | CML | U.S. Agency CMO |
CLN and Other
1
|
||||||||||
SPE assets (UPB)
2,3
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||
Retained interests | ||||||||||||||
Investment grade | $ |
|
$ |
|
$ |
|
$ |
|
||||||
Non-investment grade |
|
|
|
|
||||||||||
Total | $ |
|
$ |
|
$ |
|
$ |
|
||||||
Interests purchased in the secondary market
3
|
||||||||||||||
Investment grade | $ |
|
$ |
|
$ |
|
$ |
|
||||||
Non-investment grade |
|
|
|
|
||||||||||
Total | $ |
|
$ |
|
$ |
|
$ |
|
||||||
Derivative assets | $ |
|
$ |
|
$ |
|
$ |
|
||||||
Derivative liabilities |
|
|
|
|
At December 31, 2022 | ||||||||||||||
$ in millions | RML | CML | U.S. Agency CMO |
CLN and Other
1
|
||||||||||
SPE assets (UPB)
2,3
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||
Retained interests | ||||||||||||||
Investment grade | $ |
|
$ |
|
$ |
|
$ |
|
||||||
Non-investment grade |
|
|
|
|
||||||||||
Total | $ |
|
$ |
|
$ |
|
$ |
|
||||||
Interests purchased in the secondary market
3
|
||||||||||||||
Investment grade | $ |
|
$ |
|
$ |
|
$ |
|
||||||
Non-investment grade |
|
|
|
|
||||||||||
Total | $ |
|
$ |
|
$ |
|
$ |
|
||||||
Derivative assets | $ |
|
$ |
|
$ |
|
$ |
|
||||||
Derivative liabilities |
|
|
|
|
Fair Value At March 31, 2023 | |||||||||||
$ in millions | Level 2 | Level 3 | Total | ||||||||
Retained interests | |||||||||||
Investment grade | $ |
|
$ |
|
$ |
|
|||||
Non-investment grade |
|
|
|
||||||||
Total | $ |
|
$ |
|
$ |
|
|||||
Interests purchased in the secondary market
3
|
|||||||||||
Investment grade | $ |
|
$ |
|
$ |
|
|||||
Non-investment grade |
|
|
|
||||||||
Total | $ |
|
$ |
|
$ |
|
|||||
Derivative assets | $ |
|
$ |
|
$ |
|
|||||
Derivative liabilities |
|
|
|
Fair Value at December 31, 2022 | |||||||||||
$ in millions | Level 2 | Level 3 | Total | ||||||||
Retained interests | |||||||||||
Investment grade | $ |
|
$ |
|
$ |
|
|||||
Non-investment grade |
|
|
|
||||||||
Total | $ |
|
$ |
|
$ |
|
|||||
Interests purchased in the secondary market
3
|
|||||||||||
Investment grade | $ |
|
$ |
|
$ |
|
|||||
Non-investment grade |
|
|
|
||||||||
Total | $ |
|
$ |
|
$ |
|
|||||
Derivative assets | $ |
|
$ |
|
$ |
|
|||||
Derivative liabilities |
|
|
|
Three Months Ended
March 31, |
||||||||||||||
$ in millions | 2023 | 2022 | ||||||||||||
New transactions
1
|
$ |
|
$ |
|
||||||||||
Retained interests |
|
|
||||||||||||
Sales of corporate loans to CLO SPEs
1, 2
|
|
|
$ in millions |
At
March 31, 2023 |
At
December 31, 2022 |
||||||
Gross cash proceeds from sale of assets
1
|
$ |
|
$ |
|
||||
Fair value | ||||||||
Assets sold | $ |
|
$ |
|
||||
Derivative assets recognized in the balance sheet |
|
|
||||||
Derivative liabilities recognized in the balance sheet |
|
|
59
|
March 2023 Form 10-Q |
Notes to Consolidated Financial Statements
(Unaudited) |
![]() |
At March 31, 2023
and
December 31, 2022
|
||||||||
Standardized | Advanced | |||||||
Capital buffers | ||||||||
Capital conservation buffer | — |
|
||||||
SCB |
|
N/A | ||||||
G-SIB capital surcharge |
|
|
||||||
CCyB
1
|
|
|
||||||
Capital buffer requirement |
|
|
Regulatory Minimum |
At March 31, 2023
and
December 31, 2022
|
||||||||||
Standardized | Advanced | ||||||||||
Required ratios
1
|
|||||||||||
Common Equity Tier 1 capital ratio |
|
% |
|
|
|||||||
Tier 1 capital ratio |
|
% |
|
|
|||||||
Total capital ratio |
|
% |
|
|
$ in millions |
Required
Ratio 1 |
At March 31,
2023 |
At December 31, 2022 | |||||||||||||||||
Risk-based capital | ||||||||||||||||||||
Common Equity Tier 1 capital | $ |
|
$ |
|
||||||||||||||||
Tier 1 capital |
|
|
||||||||||||||||||
Total capital |
|
|
||||||||||||||||||
Total RWA |
|
|
||||||||||||||||||
Common Equity Tier 1 capital ratio |
|
% |
|
% |
|
% | ||||||||||||||
Tier 1 capital ratio |
|
% |
|
% |
|
% | ||||||||||||||
Total capital ratio |
|
% |
|
% |
|
% | ||||||||||||||
$ in millions |
Required
Ratio
1
|
At March 31,
2023 |
At December 31, 2022 | |||||||||||||||||
Leverage-based capital | ||||||||||||||||||||
Adjusted average assets
2
|
$ |
|
$ |
|
||||||||||||||||
Tier 1 leverage ratio |
|
% |
|
% |
|
% | ||||||||||||||
Supplementary leverage exposure
3
|
$ |
|
$ |
|
||||||||||||||||
SLR |
|
% |
|
% |
|
% |
March 2023 Form 10-Q |
60
|
Notes to Consolidated Financial Statements
(Unaudited) |
![]() |
Well-Capitalized Requirement |
Required Ratio
1
|
At March 31, 2023 | At December 31, 2022 | |||||||||||||||||
$ in millions | Amount | Ratio | Amount | Ratio | ||||||||||||||||
Risk-based capital | ||||||||||||||||||||
Common Equity Tier 1 capital |
|
% |
|
% | $ |
|
|
% | $ |
|
|
% | ||||||||
Tier 1 capital |
|
% |
|
% |
|
|
% |
|
|
% | ||||||||||
Total capital |
|
% |
|
% |
|
|
% |
|
|
% | ||||||||||
Leverage-based capital | ||||||||||||||||||||
Tier 1 leverage |
|
% |
|
% | $ |
|
|
% | $ |
|
|
% | ||||||||
SLR |
|
% |
|
% |
|
|
% |
|
|
% |
Well-Capitalized Requirement |
Required Ratio
1
|
At March 31, 2023 | At December 31, 2022 | |||||||||||||||||
$ in millions | Amount | Ratio | Amount | Ratio | ||||||||||||||||
Risk-based capital | ||||||||||||||||||||
Common Equity Tier 1 capital |
|
% |
|
% | $ |
|
|
% | $ |
|
|
% | ||||||||
Tier 1 capital |
|
% |
|
% |
|
|
% |
|
|
% | ||||||||||
Total capital |
|
% |
|
% |
|
|
% |
|
|
% | ||||||||||
Leverage-based capital | ||||||||||||||||||||
Tier 1 leverage |
|
% |
|
% | $ |
|
|
% | $ |
|
|
% | ||||||||
SLR |
|
% |
|
% |
|
|
% |
|
|
% |
$ in millions |
At March 31,
2023 |
At December 31,
2022 |
||||||
Net capital | $ |
|
$ |
|
||||
Excess net capital |
|
|
61
|
March 2023 Form 10-Q |
Notes to Consolidated Financial Statements
(Unaudited) |
![]() |
Shares Outstanding | Carrying Value | |||||||||||||
$ in millions, except per share data |
At
March 31, 2023 |
Liquidation
Preference per Share |
At
March 31, 2023 |
At
December 31, 2022 |
||||||||||
Series | ||||||||||||||
A |
|
$ |
|
$ |
|
$ |
|
|||||||
C
1
|
|
|
|
|
||||||||||
E |
|
|
|
|
||||||||||
F |
|
|
|
|
||||||||||
I |
|
|
|
|
||||||||||
K |
|
|
|
|
||||||||||
L |
|
|
|
|
||||||||||
M |
|
|
|
|
||||||||||
N |
|
|
|
|
||||||||||
O |
|
|
|
|
||||||||||
P |
|
|
|
|
||||||||||
Total | $ |
|
$ |
|
||||||||||
Shares authorized |
|
Three Months Ended March 31, | ||||||||||||||
$ in millions | 2023 | 2022 | ||||||||||||
Repurchases of common stock under the Firm’s Share Repurchase Authorization | $ |
|
$ |
|
Three Months Ended
March 31, |
||||||||||||||
in millions | 2023 | 2022 | ||||||||||||
Weighted average common shares outstanding, basic |
|
|
||||||||||||
Effect of dilutive RSUs and PSUs |
|
|
||||||||||||
Weighted average common shares outstanding and common stock equivalents, diluted |
|
|
||||||||||||
Weighted average antidilutive common stock equivalents (excluded from the computation of diluted EPS) |
|
|
$ in millions, except per
share data |
Three Months Ended
March 31, 2023 |
Three Months Ended
March 31, 2022 |
||||||||||||
Per Share
1
|
Total |
Per Share
1
|
Total | |||||||||||
Preferred stock series | ||||||||||||||
A | $ |
|
$ |
|
$ |
|
$ |
|
||||||
C |
|
|
|
|
||||||||||
E |
|
|
|
|
||||||||||
F |
|
|
|
|
||||||||||
I |
|
|
|
|
||||||||||
K |
|
|
|
|
||||||||||
L |
|
|
|
|
||||||||||
M
2
|
|
|
|
|
||||||||||
N
3
|
|
|
|
|
||||||||||
O
4
|
|
|
|
|
||||||||||
P |
|
|
|
|
||||||||||
Total Preferred stock | $ |
|
$ |
|
||||||||||
Common stock | $ |
|
$ |
|
$ |
|
$ |
|
$ in millions | CTA | AFS Securities | Pension and Other | DVA | Cash Flow Hedges | Total | ||||||||||||||
December 31, 2022 | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||
OCI during the period |
|
|
(
|
(
|
|
|
||||||||||||||
March 31, 2023 | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
||||||||
December 31, 2021 | $ |
(
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
||||||||
OCI during the period |
(
|
(
|
|
|
|
(
|
||||||||||||||
March 31, 2022 | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
||||||||
March 2023 Form 10-Q |
62
|
Notes to Consolidated Financial Statements
(Unaudited) |
![]() |
Three Months Ended March 31, 2023 | |||||||||||||||||
$ in millions | Pre-tax Gain (Loss) | Income Tax Benefit (Provision) | After-tax Gain (Loss) | Non-controlling Interests | Net | ||||||||||||
CTA | |||||||||||||||||
OCI activity | $ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||
Reclassified to earnings |
|
|
|
|
|
||||||||||||
Net OCI | $ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||
Change in net unrealized gains (losses) on AFS securities | |||||||||||||||||
OCI activity | $ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
|||||||
Reclassified to earnings |
(
|
|
(
|
|
(
|
||||||||||||
Net OCI | $ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
|||||||
Pension and other | |||||||||||||||||
OCI activity | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||
Reclassified to earnings |
(
|
|
(
|
|
(
|
||||||||||||
Net OCI | $ |
(
|
$ |
|
$ |
(
|
$ |
|
$ |
(
|
|||||||
Change in net DVA | |||||||||||||||||
OCI activity | $ |
(
|
$ |
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||
Reclassified to earnings |
|
(
|
|
|
|
||||||||||||
Net OCI | $ |
(
|
$ |
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||
Change in fair value of cash flow hedge derivatives | |||||||||||||||||
OCI activity | $ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
|||||||
Reclassified to earnings |
|
|
|
|
|
||||||||||||
Net OCI | $ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
Three Months Ended March 31, 2022 | |||||||||||||||||
$ in millions | Pre-tax Gain (Loss) | Income Tax Benefit (Provision) | After-tax Gain (Loss) | Non-controlling Interests | Net | ||||||||||||
CTA | |||||||||||||||||
OCI activity | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||
Reclassified to earnings |
|
|
|
|
|
||||||||||||
Net OCI | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||
Change in net unrealized gains (losses) on AFS securities | |||||||||||||||||
OCI activity | $ |
(
|
$ |
|
$ |
(
|
$ |
|
$ |
(
|
|||||||
Reclassified to earnings |
(
|
|
(
|
|
(
|
||||||||||||
Net OCI | $ |
(
|
$ |
|
$ |
(
|
$ |
|
$ |
(
|
|||||||
Pension and other | |||||||||||||||||
OCI activity | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||
Reclassified to earnings |
|
|
|
|
|
||||||||||||
Net OCI | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||
Change in net DVA | |||||||||||||||||
OCI activity | $ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
|||||||
Reclassified to earnings |
|
|
|
|
|
||||||||||||
Net OCI | $ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
Three Months Ended
March 31, |
||||||||||||||
$ in millions | 2023 | 2022 | ||||||||||||
Interest income | ||||||||||||||
Investment securities | $ |
|
$ |
|
||||||||||
Loans |
|
|
||||||||||||
Securities purchased under agreements to resell
1
|
|
|
||||||||||||
Securities borrowed
2
|
|
(
|
||||||||||||
Trading assets, net of Trading liabilities |
|
|
||||||||||||
Customer receivables and Other
3
|
|
|
||||||||||||
Total interest income | $ |
|
$ |
|
||||||||||
Interest expense | ||||||||||||||
Deposits | $ |
|
$ |
|
||||||||||
Borrowings |
|
|
||||||||||||
Securities sold under agreements to repurchase
4
|
|
|
||||||||||||
Securities loaned
5
|
|
|
||||||||||||
Customer payables and Other
6
|
|
(
|
||||||||||||
Total interest expense | $ |
|
$ |
|
||||||||||
Net interest | $ |
|
$ |
|
$ in millions |
At March 31,
2023 |
At December 31,
2022 |
||||||
Customer and other receivables | $ |
|
$ |
|
||||
Customer and other payables |
|
|
63
|
March 2023 Form 10-Q |
Notes to Consolidated Financial Statements
(Unaudited) |
![]() |
Three Months Ended March 31, 2023 | |||||||||||||||||
$ in millions | IS | WM | IM | I/E | Total | ||||||||||||
Investment banking | $ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||
Trading |
|
|
(
|
|
|
||||||||||||
Investments |
|
|
|
|
|
||||||||||||
Commissions and fees
1
|
|
|
|
(
|
|
||||||||||||
Asset management
1,2
|
|
|
|
(
|
|
||||||||||||
Other |
|
|
(
|
(
|
|
||||||||||||
Total non-interest revenues |
|
|
|
(
|
|
||||||||||||
Interest income |
|
|
|
(
|
|
||||||||||||
Interest expense |
|
|
|
(
|
|
||||||||||||
Net interest |
|
|
(
|
|
|
||||||||||||
Net revenues | $ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||
Provision for credit losses | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||
Compensation and benefits |
|
|
|
|
|
||||||||||||
Non-compensation expenses |
|
|
|
(
|
|
||||||||||||
Total non-interest expenses | $ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||
Income before provision for income taxes | $ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||
Provision for income taxes |
|
|
|
(
|
|
||||||||||||
Net income |
|
|
|
(
|
|
||||||||||||
Net income applicable to noncontrolling interests |
|
|
|
|
|
||||||||||||
Net income applicable to Morgan Stanley | $ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
Three Months Ended March 31, 2022 | |||||||||||||||||
$ in millions | IS | WM | IM | I/E | Total | ||||||||||||
Investment banking | $ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||
Trading |
|
(
|
(
|
|
|
||||||||||||
Investments |
|
|
(
|
|
|
||||||||||||
Commissions and fees
1
|
|
|
|
(
|
|
||||||||||||
Asset management
1,2
|
|
|
|
(
|
|
||||||||||||
Other |
|
|
(
|
(
|
|
||||||||||||
Total non-interest revenues |
|
|
|
(
|
|
||||||||||||
Interest income |
|
|
|
(
|
|
||||||||||||
Interest expense |
|
|
|
(
|
|
||||||||||||
Net interest |
|
|
(
|
|
|
||||||||||||
Net revenues | $ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||
Provision for credit losses | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||
Compensation and benefits |
|
|
|
|
|
||||||||||||
Non-compensation expenses |
|
|
|
(
|
|
||||||||||||
Total non-interest expenses | $ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||
Income before provision for income taxes | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||
Provision for income taxes |
|
|
|
|
|
||||||||||||
Net income |
|
|
|
|
|
||||||||||||
Net income applicable to noncontrolling interests |
|
|
(
|
|
|
||||||||||||
Net income applicable to Morgan Stanley | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
Three Months Ended
March 31, |
||||||||||||||
$ in millions | 2023 | 2022 | ||||||||||||
Institutional Securities Advisory | $ |
|
$ |
|
||||||||||
Institutional Securities Underwriting |
|
|
||||||||||||
Firm Investment banking revenues from contracts with customers |
|
% |
|
% |
Three Months Ended
March 31, |
||||||||||||||
$ in millions | 2023 | 2022 | ||||||||||||
Interest rate | $ |
|
$ |
|
||||||||||
Foreign exchange |
|
|
||||||||||||
Equity
1
|
|
|
||||||||||||
Commodity and other |
|
|
||||||||||||
Credit |
|
|
||||||||||||
Total | $ |
|
$ |
|
$ in millions |
At
March 31, 2023 |
At
December 31, 2022 |
||||||
Net cumulative unrealized performance-based fees at risk of reversing | $ |
|
$ |
|
Three Months Ended
March 31, |
||||||||||||||
$ in millions | 2023 | 2022 | ||||||||||||
Fee waivers | $ |
|
$ |
|
March 2023 Form 10-Q |
64
|
Notes to Consolidated Financial Statements
(Unaudited) |
![]() |
Three Months Ended
March 31, |
||||||||||||||
$ in millions | 2023 | 2022 | ||||||||||||
Transaction taxes | $ |
|
$ |
|
Three Months Ended
March 31, |
||||||||||||||
$ in millions | 2023 | 2022 | ||||||||||||
Americas | $ |
|
$ |
|
||||||||||
EMEA |
|
|
||||||||||||
Asia |
|
|
||||||||||||
Total | $ |
|
$ |
|
Three Months Ended
March 31, |
||||||||||||||
$ in millions | 2023 | 2022 | ||||||||||||
Non-interest revenues | $ |
|
$ |
|
$ in millions |
At
March 31, 2023 |
At
December 31, 2022 |
||||||
Customer and other receivables | $ |
|
$ |
|
$ in millions |
At
March 31, 2023 |
At
December 31, 2022 |
||||||
Institutional Securities | $ |
|
$ |
|
||||
Wealth Management |
|
|
||||||
Investment Management |
|
|
||||||
Total
1
|
$ |
|
$ |
|
65
|
March 2023 Form 10-Q |
Three Months Ended March 31, | ||||||||||||||||||||
2023 | 2022 | |||||||||||||||||||
$ in millions | Average Daily Balance | Interest | Annualized Average Rate | Average Daily Balance | Interest | Annualized Average Rate | ||||||||||||||
Interest earning assets | ||||||||||||||||||||
Investment securities
1
|
$ | 159,061 | $ | 1,018 | 2.6 | % | $ | 177,572 | $ | 777 | 1.8 | % | ||||||||
Loans
1
|
214,185 | 2,815 | 5.3 | % | 191,551 | 1,156 | 2.4 | % | ||||||||||||
Securities purchased under agreements to resell
2
:
|
||||||||||||||||||||
U.S. | 46,847 | 932 | 8.1 | % | 52,389 | 36 | 0.3 | % | ||||||||||||
Non-U.S. | 65,713 | 545 | 3.4 | % | 64,150 | (23) | (0.1) | % | ||||||||||||
Securities borrowed
3
:
|
||||||||||||||||||||
U.S. | 123,206 | 1,095 | 3.6 | % | 122,203 | (176) | (0.6) | % | ||||||||||||
Non-U.S. | 18,683 | 77 | 1.7 | % | 21,229 | (41) | (0.8) | % | ||||||||||||
Trading assets, net of Trading liabilities
4
:
|
||||||||||||||||||||
U.S. | 87,631 | 786 | 3.6 | % | 79,509 | 430 | 2.2 | % | ||||||||||||
Non-U.S. | 7,264 | 127 | 7.1 | % | 16,606 | 94 | 2.3 | % | ||||||||||||
Customer receivables and Other
5
:
|
||||||||||||||||||||
U.S. | 107,055 | 2,428 | 9.2 | % | 129,162 | 355 | 1.1 | % | ||||||||||||
Non-U.S. | 69,288 | 1,047 | 6.1 | % | 76,545 | 42 | 0.2 | % | ||||||||||||
Total | $ | 898,933 | $ | 10,870 | 4.9 | % | $ | 930,916 | $ | 2,650 | 1.2 | % | ||||||||
Interest bearing liabilities | ||||||||||||||||||||
Deposits
1
|
$ | 346,973 | $ | 1,575 | 1.8 | % | $ | 348,916 | $ | 73 | 0.1 | % | ||||||||
Borrowings
1,6
|
245,600 | 2,506 | 4.1 | % | 228,942 | 685 | 1.2 | % | ||||||||||||
Securities sold under agreements to repurchase
7,9
:
|
||||||||||||||||||||
U.S. | 21,075 | 670 | 12.9 | % | 22,979 | 40 | 0.7 | % | ||||||||||||
Non-U.S. | 41,071 | 548 | 5.4 | % | 36,148 | 9 | 0.1 | % | ||||||||||||
Securities loaned
8,9
:
|
||||||||||||||||||||
U.S. | 4,992 | 13 | 1.1 | % | 5,489 | (1) | (0.1) | % | ||||||||||||
Non-U.S. | 10,016 | 151 | 6.1 | % | 7,771 | 94 | 4.9 | % | ||||||||||||
Customer payables and Other
10
:
|
||||||||||||||||||||
U.S. | 137,766 | 2,045 | 6.0 | % | 136,407 | (368) | (1.1) | % | ||||||||||||
Non-U.S. | 65,818 | 1,016 | 6.3 | % | 74,919 | (98) | (0.5) | % | ||||||||||||
Total | $ | 873,311 | $ | 8,524 | 4.0 | % | $ | 861,571 | $ | 434 | 0.2 | % | ||||||||
Net interest income and net interest rate spread | $ | 2,346 | 0.9 | % | $ | 2,216 | 1.0 | % |
March 2023 Form 10-Q |
66
|
Glossary of Common Terms and Acronyms |
![]() |
2022 Form 10-K | Annual report on Form 10-K for year ended December 31, 2022 filed with the SEC | ||||
ABS | Asset-backed securities | ||||
ACL | Allowance for credit losses | ||||
AFS | Available-for-sale | ||||
AML | Anti-money laundering | ||||
AOCI | Accumulated other comprehensive income (loss) | ||||
AUM | Assets under management or supervision | ||||
Balance sheet | Consolidated balance sheet | ||||
BHC | Bank holding company | ||||
bps | Basis points; one basis point equals 1/100th of 1% | ||||
Cash flow statement | Consolidated cash flow statement | ||||
CCAR | Comprehensive Capital Analysis and Review | ||||
CCyB | Countercyclical capital buffer | ||||
CDO | Collateralized debt obligation(s), including Collateralized loan obligation(s) | ||||
CDS | Credit default swaps | ||||
CECL | Current Expected Credit Losses, as calculated under the Financial Instruments—Credit Losses accounting update | ||||
CFTC | U.S. Commodity Futures Trading Commission | ||||
CLN | Credit-linked note(s) | ||||
CLO | Collateralized loan obligation(s) | ||||
CMBS | Commercial mortgage-backed securities | ||||
CMO | Collateralized mortgage obligation(s) | ||||
CRM | Credit Risk Management Department | ||||
CTA | Cumulative foreign currency translation adjustments | ||||
DVA | Debt valuation adjustment | ||||
EBITDA | Earnings before interest, taxes, depreciation and amortization | ||||
EMEA | Europe, Middle East and Africa | ||||
EPS | Earnings per common share | ||||
FDIC | Federal Deposit Insurance Corporation | ||||
FFELP | Federal Family Education Loan Program | ||||
FHC | Financial holding company | ||||
FICO | Fair Isaac Corporation | ||||
Financial statements | Consolidated financial statements | ||||
FVO | Fair value option | ||||
G-SIB | Global systemically important banks | ||||
HFI | Held-for-investment | ||||
HFS | Held-for-sale | ||||
HQLA | High-quality liquid assets | ||||
HTM | Held-to-maturity | ||||
I/E | Intersegment eliminations | ||||
IHC | Intermediate holding company | ||||
IM | Investment Management | ||||
Income statement | Consolidated income statement | ||||
IRS | Internal Revenue Service | ||||
IS | Institutional Securities |
LCR | Liquidity coverage ratio, as adopted by the U.S. banking agencies | ||||
LIBOR | London Interbank Offered Rate | ||||
LTV | Loan-to-value | ||||
M&A | Merger, acquisition and restructuring transaction | ||||
MSBNA | Morgan Stanley Bank, N.A. | ||||
MS&Co. | Morgan Stanley & Co. LLC | ||||
MSCG | Morgan Stanley Capital Group Inc. | ||||
MSCS | Morgan Stanley Capital Services LLC | ||||
MSEHSE | Morgan Stanley Europe Holdings SE | ||||
MSESE | Morgan Stanley Europe SE | ||||
MSIP | Morgan Stanley & Co. International plc | ||||
MSMS | Morgan Stanley MUFG Securities Co., Ltd. | ||||
MSPBNA | Morgan Stanley Private Bank, National Association | ||||
MSSB | Morgan Stanley Smith Barney LLC | ||||
MUFG | Mitsubishi UFJ Financial Group, Inc. | ||||
MUMSS | Mitsubishi UFJ Morgan Stanley Securities Co., Ltd. | ||||
MWh | Megawatt hour | ||||
N/A | Not Applicable | ||||
N/M | Not Meaningful | ||||
NAV | Net asset value | ||||
Non-GAAP | Non-generally accepted accounting principles | ||||
NSFR | Net stable funding ratio, as adopted by the U.S. banking agencies | ||||
OCC | Office of the Comptroller of the Currency | ||||
OCI | Other comprehensive income (loss) | ||||
OTC | Over-the-counter | ||||
PSU | Performance-based stock unit | ||||
ROE | Return on average common equity | ||||
ROTCE | Return on average tangible common equity | ||||
ROU | Right-of-use | ||||
RSU | Restricted stock unit | ||||
RWA | Risk-weighted assets | ||||
SCB | Stress capital buffer | ||||
SEC | U.S. Securities and Exchange Commission | ||||
SLR | Supplementary leverage ratio | ||||
SOFR | Secured Overnight Financing Rate | ||||
S&P | Standard & Poor’s | ||||
SPE | Special purpose entity | ||||
SPOE | Single point of entry | ||||
TDR | Troubled debt restructuring | ||||
TLAC | Total loss-absorbing capacity | ||||
U.K. | United Kingdom | ||||
UPB | Unpaid principal balance | ||||
U.S. | United States of America | ||||
U.S. GAAP | Accounting principles generally accepted in the United States of America | ||||
VaR | Value-at-Risk | ||||
VIE | Variable interest entity | ||||
WACC | Implied weighted average cost of capital | ||||
WM | Wealth Management |
67
|
March 2023 Form 10-Q |
$ in millions, except per share data |
Total Number of Shares Purchased
1
|
Average Price Paid per Share
2
|
Total Shares Purchased as Part of Share Repurchase Authorization
3,4
|
Dollar Value of Remaining Authorized Repurchase | ||||||||||
January | 8,974,630 | $ | 96.61 | 2,725,102 | $ | 15,484 | ||||||||
February | 7,212,253 | $ | 98.48 | 6,284,841 | $ | 14,865 | ||||||||
March | 6,830,645 | $ | 92.29 | 6,752,720 | $ | 14,245 | ||||||||
Three Months Ended March 31, 2023 | 23,017,528 | $ | 95.91 | 15,762,663 |
March 2023 Form 10-Q |
68
|
Exhibit No. | Description | ||||
15 | |||||
31.1 | |||||
31.2 | |||||
32.1 | |||||
32.2 | |||||
101 | Interactive Data Files pursuant to Rule 405 of Regulation S-T formatted in Inline eXtensible Business Reporting Language (“Inline XBRL”). | ||||
104 | Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101). |
MORGAN STANLEY
(Registrant)
|
|||||
By: |
/s/ S
HARON
Y
ESHAYA
|
||||
Sharon Yeshaya
Executive Vice President and Chief Financial Officer |
|||||
By: |
/s/ R
AJA
J. A
KRAM
|
||||
Raja J. Akram
Deputy Chief Financial Officer, Chief Accounting Officer and Controller |
69
|
March 2023 Form 10-Q |
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|
No information found
No Customers Found
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|